199 results on '"Perez MJ"'
Search Results
2. International incidence of childhood cancer, 2001–10: a population-based registry study
- Author
-
Bouzbid, S, Hamdi-Cherif, M, Hablas, A, Chirpaz, E, Buziba, N, Chesumbai, GC, Manraj, SS, Reynders, D, Wabinga, HR, Chokunonga, E, Moreno, F, Lima, CA, Asturian Laporte, C, de Oliveira, JC, de Aquino, JA Pontes, Gallagher, SM Vargas, Uribe, CJ, Bravo, LE, Yepez Chamorro, MC, Torres Alvarado, G, Galán Alvarez, YH, Martinez Reyes, FC, Castillo Calvas, JC, Mendoza Alava, M, Cueva Ayala, P, Hanchard, B, Fajardo-Gutiérrez, A, Zavala Zegarra, DE, Barrios, E, Nikiforuk, C, Woods, R, Turner, D, MacIntyre, M, Corriveau, A, Navaneelan, T, Bertrand, C, Stuart-Panko, H, Wilson, RJ, Kosary, C, Shen, X, Brockhouse, J, Yee, GA, Mitchell, TC, Snipes, K, West, D, Rao, C, Bolick, S, Rycroft, RK, Mueller, L, Zheng, Y, Dosch, K, Brown, H, Vargas, A, Levin, GM, Bayakly, R, Johnson, C, Shen, T, Ruppert, L, Lynch, CF, Lai, SM, Tucker, TC, Wu, XC, Schwenn, M, Stern, K, Gershman, S, Copeland, G, Bushhouse, S, Rogers, DB, Jackson Thompson, J, Lemons, D, Frederick, S, Harris, JA, Riddle, B, Stroup, A, Wiggins, C, Schymura, MJ, Giljahn, LK, Sheikh, A, Schubert, S, Aldinger, W, Fulton, JP, Whiteside, M, Nogueira, L, Sweeney, C, Johnson, A, Martin, J, Farley, S, Harrelson, D, Malicki, R, Espinoza, JR, Hernandez, BY, Abulfateh, N, Wang, N, Ngan, RKC, Lingegowda, KB, Swaminathan, R, Koyande, SS, Silverman, B, Ozasa, K, Kanemura, S, Soda, M, Miyashiro, I, Shibata, A, Nimri, O, Won, YJ, Kim, CH, Hong, NS, Nam, HS, Kweon, S, Kim, WC, Huh, JS, Jung, KW, Yoo, CI, Elbasmy, A, Laudico, AV, Lumague, MR, AlMutlag, H, Buasom, R, Srisukho, S, Tanabodee, J, Wiangnon, S, Pongnikorn, D, Sriplung, H, Dirican, O, Eser, S, Le Hoang, M, Hackl, M, Zborovskaya, A, Dimitrova, N, Valerianova, Z, Sekerija, M, Pavlou, P, Dušek, M, Mägi, M, Clavel, J, Lacour, B, Guizard, AV, Bouvier, V, Troussard, X, Woronoff, AS, Tretarre, B, Colonna, M, Molinié, F, Bara, S, Velten, M, Marrer, E, Ganry, O, Grosclaude, P, Kaatsch, P, Zeissig, SR, Holleczek, B, Katalinic, A, Jakab, Z, Birgisson, H, Walsh, PM, Mangone, L, Merletti, F, Magoni, M, Ferretti, S, Serraino, D, Spagnoli, G, Fusco, M, Michiara, M, Tumino, R, Falcini, F, Sensi, F, Tisano, F, Piffer, S, Stracci, F, Tagliabue, G, Smailyte, G, Agius, D, Visser, O, Ursin, G, Didkowska, J, Trojanowski, M, Wojciechowska, U, Forjaz de Lacerda, G, Silva, MA, Laranja Pontes, J, da Costa Miranda, A, Kaiserova, E, Primic Žakelj, M, Peris-Bonet, R, Vicente Raneda, ML, Almar Marqués, E, Quirós Garcia, JR, Ramos Monserrat, M, Errezola Saizar, M, Alemán Herrera, A, Díaz García, JM, Marcos-Gragera, R, Sanchez-Perez, MJ, Ardanaz Aicua, E, Galceran, J, Klint, A, Kuehni, CE, Bouchardy, C, Levi, F, Bordoni, A, Konzelmann, I, Rohrmann, S, Stiller, CA, Gavin, AT, Brewster, DH, Phung, H, Rushton, S, Guthridge, S, Aitken, J, D'Onise, K, Venn, A, Farrugian, H, Threlfall, TJ, Laumond, S, Yen Kai Sun, L, Hendrix, J, Ballantine, K, Colombet, M, Dolya, A, Masuyer, E, Steliarova-Foucher, E, Steliarova-Foucher, Eva, Colombet, Murielle, Ries, Lynn A G, Moreno, Florencia, Dolya, Anastasia, Bray, Freddie, Hesseling, Peter, Shin, Hee Young, and Stiller, Charles A
- Published
- 2017
- Full Text
- View/download PDF
3. Association of Pre-diagnostic Antibody Responses to Escherichia coli and Bacteroides fragilis Toxin Proteins with Colorectal Cancer in a European Cohort
- Author
-
Butt, J, Jenab, M, Werner, J, Fedirko, V, Weiderpass, E, Dahm, CC, Tjonneland, A, Olsen, A, Boutron-Ruault, M-C, Rothwell, JA, Severi, G, Kaaks, R, Turzanski-Fortner, R, Aleksandrova, K, Schulze, M, Palli, D, Pala, V, Panico, S, Tumino, R, Sacerdote, C, Bueno-de-Mesquita, B, Van Gils, CH, Gram, IT, Lukic, M, Sala, N, Sanchez Perez, MJ, Ardanaz, E, Chirlaque, M-D, Palmquist, R, Lowenmark, T, Travis, RC, Heath, A, Cross, AJ, Freisling, H, Zouiouich, S, Aglago, E, Waterboer, T, Hughes, DJ, Butt, J, Jenab, M, Werner, J, Fedirko, V, Weiderpass, E, Dahm, CC, Tjonneland, A, Olsen, A, Boutron-Ruault, M-C, Rothwell, JA, Severi, G, Kaaks, R, Turzanski-Fortner, R, Aleksandrova, K, Schulze, M, Palli, D, Pala, V, Panico, S, Tumino, R, Sacerdote, C, Bueno-de-Mesquita, B, Van Gils, CH, Gram, IT, Lukic, M, Sala, N, Sanchez Perez, MJ, Ardanaz, E, Chirlaque, M-D, Palmquist, R, Lowenmark, T, Travis, RC, Heath, A, Cross, AJ, Freisling, H, Zouiouich, S, Aglago, E, Waterboer, T, and Hughes, DJ
- Abstract
Experimental evidence has implicated genotoxic Escherichia coli (E. coli) and enterotoxigenic Bacteroides fragilis (ETBF) in the development of colorectal cancer (CRC). However, evidence from epidemiological studies is sparse. We therefore assessed the association of serological markers of E. coli and ETBF exposure with odds of developing CRC in the European Prospective Investigation into Nutrition and Cancer (EPIC) study.Serum samples of incident CRC cases and matched controls (n = 442 pairs) were analyzed for immunoglobulin (Ig) A and G antibody responses to seven E. coli proteins and two isoforms of the ETBF toxin via multiplex serology. Multivariable-adjusted conditional logistic regression analyses were used to estimate odds ratios (ORs) and 95% confidence intervals (CIs) for the association of sero-positivity to E. coli and ETBF with CRC.The IgA-positivity of any of the tested E. coli antigens was associated with higher odds of developing CRC (OR: 1.42; 95% CI: 1.05-1.91). Dual-positivity for both IgA and IgG to E. coli and ETBF was associated with >1.7-fold higher odds of developing CRC, with a significant association only for IgG (OR: 1.75; 95% CI: 1.04, 2.94). This association was more pronounced when restricted to the proximal colon cancers (OR: 2.62; 95% CI: 1.09, 6.29) compared to those of the distal colon (OR: 1.24; 95% CI: 0.51, 3.00) (pheterogeneity = 0.095). Sero-positivity to E. coli and ETBF was associated with CRC development, suggesting that co-infection of these bacterial species may contribute to colorectal carcinogenesis. These findings warrant further exploration in larger prospective studies and within different population groups.
- Published
- 2021
4. Peer Review #1 of "Isotopic biomonitoring of anthropic carbon emissions in a megalopolis (v0.1)"
- Author
-
Cach Perez, MJ, additional
- Published
- 2020
- Full Text
- View/download PDF
5. PLZF-RAR(alpha), NPM1-RAR(alpha), and Other Acute Promyelocytic Leukemia Variants: The PETHEMA Registry Experience and Systematic Literature Review
- Author
-
Sobas, M, Talarn-Forcadell, MC, Martinez-Cuadron, D, Escoda, L, Garcia-Perez, MJ, Mariz, J, Mela-Osorio, MJ, Fernandez, I, Alonso-Dominguez, JM, Cornago-Navascues, J, Rodriguez-Macias, G, Amutio, ME, Rodriguez-Medina, C, Esteve, J, Sokol, A, Murciano-Carrillo, T, Calasanz, MJ, Barrios, M, Barragan, E, Sanz, MA, and Montesinos, P
- Subjects
variant ,systematic review ,characteristics ,acute promyelocytic leukemia ,outcomes ,neoplasms - Abstract
It has been suggested that 1-2% of acute promyelocytic leukemia (APL) patients present variant rearrangements of retinoic acid receptor alpha (RAR alpha) fusion gene, with the promyelocytic leukaemia zinc finger (PLZF)/RAR(alpha) being the most frequent. Resistance to all-trans-retinoic acid (ATRA) and arsenic trioxide (ATO) has been suggested in PLZF/RAR(alpha) and other variant APLs. Herein, we analyze the incidence, characteristics, and outcomes of variant APLs reported to the multinational PETHEMA (Programa para el Tratamiento de Hemopatias Malignas) registry, and we perform a systematic review in order to shed light on strategies to improve management of these extremely rare diseases. Of 2895 patients with genetically confirmed APL in the PETHEMA registry, 11 had variant APL (0.4%) (9 PLZF-RAR(alpha) and 2 NPM1-RAR(alpha)), 9 were men, with median age of 44.6 years (3 months to 76 years), median leucocytes (WBC) 16.8 x 10(9)/L, and frequent coagulopathy. Eight patients were treated with ATRA plus chemotherapy-based regimens, and 3 with chemotherapy-based. As compared to previous reports, complete remission and survival was slightly better in our cohort, with 73% complete remission (CR) and 73% survival despite a high relapse rate (43%). After analyzing our series and performing a comprehensive and critical review of the literature, strong recommendations on appropriate management of variant APL are not possible due to the low number and heterogeneity of patients reported so far.
- Published
- 2020
6. Mediation analysis of the alcohol-postmenopausal breast cancer relationship by sex hormones in the EPIC cohort
- Author
-
Assi, N, Rinaldi, S, Viallon, V, Dashti, SG, Dossus, L, Fournier, A, Cervenka, I, Kvaskoff, M, Turzanski-Fortner, R, Bergmann, M, Boeing, H, Panico, S, Ricceri, F, Palli, D, Tumino, R, Grioni, S, Sanchez Perez, MJ, Chirlaque, M-D, Bonet, C, Barricarte Gurrea, A, Amiano Etxezarreta, P, Merino, S, de Mesquita, HBB, van Gils, CH, Onland-Moret, C, Tjonneland, A, Overvad, K, Trichopoulou, A, Martimianaki, G, Karakatsani, A, Key, T, Christakoudi, S, Ellingjord-Dale, M, Tsilidis, K, Riboli, E, Kaaks, R, Gunter, MJ, Ferrari, P, Assi, N, Rinaldi, S, Viallon, V, Dashti, SG, Dossus, L, Fournier, A, Cervenka, I, Kvaskoff, M, Turzanski-Fortner, R, Bergmann, M, Boeing, H, Panico, S, Ricceri, F, Palli, D, Tumino, R, Grioni, S, Sanchez Perez, MJ, Chirlaque, M-D, Bonet, C, Barricarte Gurrea, A, Amiano Etxezarreta, P, Merino, S, de Mesquita, HBB, van Gils, CH, Onland-Moret, C, Tjonneland, A, Overvad, K, Trichopoulou, A, Martimianaki, G, Karakatsani, A, Key, T, Christakoudi, S, Ellingjord-Dale, M, Tsilidis, K, Riboli, E, Kaaks, R, Gunter, MJ, and Ferrari, P
- Abstract
Alcohol consumption is associated with higher risk of breast cancer (BC); however, the biological mechanisms underlying this association are not fully elucidated, particularly the extent to which this relationship is mediated by sex hormone levels. Circulating concentrations of estradiol, testosterone, their free fractions and sex-hormone binding globulin (SHBG), were examined in 430 incident BC cases and 645 matched controls among alcohol-consuming postmenopausal women nested within the European Prospective Investigation into Cancer and Nutrition. Mediation analysis was applied to assess whether individual hormone levels mediated the relationship between alcohol intake and BC risk. An alcohol-related hormonal signature, obtained by partial least square (PLS) regression, was evaluated as a potential mediator. Total (TE), natural direct and natural indirect effects (NIE) were estimated. Alcohol intake was positively associated with overall BC risk and specifically with estrogen receptor-positive tumors with respectively TE = 1.17(95%CI: 1.01,1.35) and 1.36(1.08,1.70) for a 1-standard deviation (1-SD) increase of intake. There was no evidence of mediation by sex steroids or SHBG separately except for a weak indirect effect through free estradiol where NIE = 1.03(1.00,1.06). However, an alcohol-related hormonal signature negatively associated with SHBG and positively with estradiol and testosterone was associated with BC risk (odds ratio [OR] = 1.25 [1.07,1.47]) for a 1-SD higher PLS score, and had a statistically significant NIE accounting for a mediated proportion of 24%. There was limited evidence of mediation of the alcohol-BC association by individual sex hormones. However, a hormonal signature, reflecting lower levels of SHBG and higher levels of sex steroids, mediated a substantial proportion of the association.
- Published
- 2020
7. PATIENT SATISFACTION AFTER THE REALIZATION OF AN ENDOSCOPY: A QUALITY CRITERIA IN OUR UNITS
- Author
-
Fernández, N, additional, Amelia Cid, L, additional, Arroyo Alonso, JA, additional, Rial Fernández, MJ, additional, Hermida Perez, MJ, additional, Salgado, A, additional, Estevez, P, additional, and Rodríguez Prada, JI, additional
- Published
- 2019
- Full Text
- View/download PDF
8. Effectiveness of 23-valent pneumococcal polysaccharide vaccination in preventing community-acquired pneumonia hospitalization and severe outcomes in the elderly in Spain
- Author
-
Dominguez, A, Soldevila, N, Toledo, D, Torner, N, Force, L, Perez, MJ, Martin, V, Rodriguez-Rojas, L, Astray, J, Egurrola, M, Sanz, F, Castilla, J, Cayla, J.A., Rius, C., and Morales, Mariá Manuela Del Mar
- Abstract
Pneumococcal pneumonia is a serious cause of morbidity and mortality in the elderly, but investigation of the etiological agent of community-acquired pneumonia (CAP) is not possible in most hospitalized patients. The aim of this study was to estimate the effect of pneumococcal polysaccharide vaccination (PPSV23) in preventing CAP hospitalization and reducing the risk of intensive care unit admission (ICU) and fatal outcomes in hospitalized people aged >= 65 years. We made a multicenter case-control study in 20 Spanish hospitals during 2013-2014 and 2014-2015. We selected patients aged >= 65 years hospitalized with a diagnosis of pneumonia and controls matched by sex, age and date of hospitalization. Multivariate analysis was performed using conditional logistic regression to estimate vaccine effectiveness and unconditional logistic regression to evaluate the reduction in the risk of severe and fatal outcomes. 1895 cases and 1895 controls were included; 13.7% of cases and 14.4% of controls had received PPSV23 in the last five years. The effectiveness of PPSV23 in preventing CAP hospitalization was 15.2% (95% CI-3.1-30.3). The benefit of PPSV23 in avoiding ICU admission or death was 28.1% (95% CI-14.3-56.9) in all patients, 30.9% (95% CI-32.2-67.4) in immunocompetent patients and 26.9% (95% CI-38.6-64.8) in immunocompromised patients. In conclusion, PPSV23 showed a modest trend to avoidance of hospitalizations due to CAP and to the prevention of death or ICU admission in elderly patients hospitalized with a diagnosis of CAP.
- Published
- 2017
9. International incidence of childhood cancer, 2001–10: a population-based registry study
- Author
-
Steliarova-Foucher, Eva, primary, Colombet, Murielle, additional, Ries, Lynn A G, additional, Moreno, Florencia, additional, Dolya, Anastasia, additional, Bray, Freddie, additional, Hesseling, Peter, additional, Shin, Hee Young, additional, Stiller, Charles A, additional, Bouzbid, S, additional, Hamdi-Cherif, M, additional, Hablas, A, additional, Chirpaz, E, additional, Buziba, N, additional, Chesumbai, GC, additional, Manraj, SS, additional, Reynders, D, additional, Wabinga, HR, additional, Chokunonga, E, additional, Moreno, F, additional, Lima, CA, additional, Asturian Laporte, C, additional, de Oliveira, JC, additional, de Aquino, JA Pontes, additional, Gallagher, SM Vargas, additional, Uribe, CJ, additional, Bravo, LE, additional, Yepez Chamorro, MC, additional, Torres Alvarado, G, additional, Galán Alvarez, YH, additional, Martinez Reyes, FC, additional, Castillo Calvas, JC, additional, Mendoza Alava, M, additional, Cueva Ayala, P, additional, Hanchard, B, additional, Fajardo-Gutiérrez, A, additional, Zavala Zegarra, DE, additional, Barrios, E, additional, Nikiforuk, C, additional, Woods, R, additional, Turner, D, additional, MacIntyre, M, additional, Corriveau, A, additional, Navaneelan, T, additional, Bertrand, C, additional, Stuart-Panko, H, additional, Wilson, RJ, additional, Kosary, C, additional, Shen, X, additional, Brockhouse, J, additional, Yee, GA, additional, Mitchell, TC, additional, Snipes, K, additional, West, D, additional, Rao, C, additional, Bolick, S, additional, Rycroft, RK, additional, Mueller, L, additional, Zheng, Y, additional, Dosch, K, additional, Brown, H, additional, Vargas, A, additional, Levin, GM, additional, Bayakly, R, additional, Johnson, C, additional, Shen, T, additional, Ruppert, L, additional, Lynch, CF, additional, Lai, SM, additional, Tucker, TC, additional, Wu, XC, additional, Schwenn, M, additional, Stern, K, additional, Gershman, S, additional, Copeland, G, additional, Bushhouse, S, additional, Rogers, DB, additional, Jackson Thompson, J, additional, Lemons, D, additional, Frederick, S, additional, Harris, JA, additional, Riddle, B, additional, Stroup, A, additional, Wiggins, C, additional, Schymura, MJ, additional, Giljahn, LK, additional, Sheikh, A, additional, Schubert, S, additional, Aldinger, W, additional, Fulton, JP, additional, Whiteside, M, additional, Nogueira, L, additional, Sweeney, C, additional, Johnson, A, additional, Martin, J, additional, Farley, S, additional, Harrelson, D, additional, Malicki, R, additional, Espinoza, JR, additional, Hernandez, BY, additional, Abulfateh, N, additional, Wang, N, additional, Ngan, RKC, additional, Lingegowda, KB, additional, Swaminathan, R, additional, Koyande, SS, additional, Silverman, B, additional, Ozasa, K, additional, Kanemura, S, additional, Soda, M, additional, Miyashiro, I, additional, Shibata, A, additional, Nimri, O, additional, Won, YJ, additional, Kim, CH, additional, Hong, NS, additional, Nam, HS, additional, Kweon, S, additional, Kim, WC, additional, Huh, JS, additional, Jung, KW, additional, Yoo, CI, additional, Elbasmy, A, additional, Laudico, AV, additional, Lumague, MR, additional, AlMutlag, H, additional, Buasom, R, additional, Srisukho, S, additional, Tanabodee, J, additional, Wiangnon, S, additional, Pongnikorn, D, additional, Sriplung, H, additional, Dirican, O, additional, Eser, S, additional, Le Hoang, M, additional, Hackl, M, additional, Zborovskaya, A, additional, Dimitrova, N, additional, Valerianova, Z, additional, Sekerija, M, additional, Pavlou, P, additional, Dušek, M, additional, Mägi, M, additional, Clavel, J, additional, Lacour, B, additional, Guizard, AV, additional, Bouvier, V, additional, Troussard, X, additional, Woronoff, AS, additional, Tretarre, B, additional, Colonna, M, additional, Molinié, F, additional, Bara, S, additional, Velten, M, additional, Marrer, E, additional, Ganry, O, additional, Grosclaude, P, additional, Kaatsch, P, additional, Zeissig, SR, additional, Holleczek, B, additional, Katalinic, A, additional, Jakab, Z, additional, Birgisson, H, additional, Walsh, PM, additional, Mangone, L, additional, Merletti, F, additional, Magoni, M, additional, Ferretti, S, additional, Serraino, D, additional, Spagnoli, G, additional, Fusco, M, additional, Michiara, M, additional, Tumino, R, additional, Falcini, F, additional, Sensi, F, additional, Tisano, F, additional, Piffer, S, additional, Stracci, F, additional, Tagliabue, G, additional, Smailyte, G, additional, Agius, D, additional, Visser, O, additional, Ursin, G, additional, Didkowska, J, additional, Trojanowski, M, additional, Wojciechowska, U, additional, Forjaz de Lacerda, G, additional, Silva, MA, additional, Laranja Pontes, J, additional, da Costa Miranda, A, additional, Kaiserova, E, additional, Primic Žakelj, M, additional, Peris-Bonet, R, additional, Vicente Raneda, ML, additional, Almar Marqués, E, additional, Quirós Garcia, JR, additional, Ramos Monserrat, M, additional, Errezola Saizar, M, additional, Alemán Herrera, A, additional, Díaz García, JM, additional, Marcos-Gragera, R, additional, Sanchez-Perez, MJ, additional, Ardanaz Aicua, E, additional, Galceran, J, additional, Klint, A, additional, Kuehni, CE, additional, Bouchardy, C, additional, Levi, F, additional, Bordoni, A, additional, Konzelmann, I, additional, Rohrmann, S, additional, Stiller, CA, additional, Gavin, AT, additional, Brewster, DH, additional, Phung, H, additional, Rushton, S, additional, Guthridge, S, additional, Aitken, J, additional, D'Onise, K, additional, Venn, A, additional, Farrugian, H, additional, Threlfall, TJ, additional, Laumond, S, additional, Yen Kai Sun, L, additional, Hendrix, J, additional, Ballantine, K, additional, Colombet, M, additional, Dolya, A, additional, Masuyer, E, additional, and Steliarova-Foucher, E, additional
- Published
- 2017
- Full Text
- View/download PDF
10. Hepatocellularcarcinoma risk factors and disease burden in a European cohort: a nestedcase-control study
- Author
-
Trichopoulos D, Bamia C, Lagiou P, Fedirko V, Trepo E, Jenab M, Pischon T, Nöthlings U, Overved K, Tjønneland A, Outzen M, Clavel Chapelon F, Kaaks R, Lukanova A, Boeing H, Aleksandrova K, Benetou V, Zylis D, Palli D, Pala V, Tumino R, Sacerdote C, Bueno De Mesquita HB, Van Kranen HJ, Peeters PH, Lund E, Quirós JR, González CA, Sanchez Perez MJ, Navarro C, Dorronsoro M, Barricarte A, Lindkvist B, Regnér S, Werner M, Hallmans G, Khaw KT, Wareham N, Key T, Romieu I, Chuang SC, Murphy N, Boffetta P, Trichopoulou A, Riboli E., PANICO, SALVATORE, Trichopoulos, D, Bamia, C, Lagiou, P, Fedirko, V, Trepo, E, Jenab, M, Pischon, T, Nöthlings, U, Overved, K, Tjønneland, A, Outzen, M, Clavel Chapelon, F, Kaaks, R, Lukanova, A, Boeing, H, Aleksandrova, K, Benetou, V, Zylis, D, Palli, D, Pala, V, Panico, Salvatore, Tumino, R, Sacerdote, C, Bueno De Mesquita, Hb, Van Kranen, Hj, Peeters, Ph, Lund, E, Quirós, Jr, González, Ca, Sanchez Perez, Mj, Navarro, C, Dorronsoro, M, Barricarte, A, Lindkvist, B, Regnér, S, Werner, M, Hallmans, G, Khaw, Kt, Wareham, N, Key, T, Romieu, I, Chuang, Sc, Murphy, N, Boffetta, P, Trichopoulou, A, and Riboli, E.
- Published
- 2011
11. EPIC-Heart. EPIC-Heart: the cardiovascular component of a prospective study of nutritional, lifestyle and biological factors in 520,000 middle-aged participants from 10 European countries
- Author
-
DANESH J, SARACCI R, BERGLUND G, FESKENS E, OVERVAD K, THOMPSON S, FOURNIER A, CLAVEL CHAPELON F, CANONICO M, KAAKS R, LINSEISEN J, BOEING H, PISCHON T, WEIKERT C, OLSEN A, TJONNELAND A, JOHNSEN SP, JENSEN MK, QUIROS JR, SVATETZ CA, PEREZ MJ, LARRANAGA N, SANCHEZ CN, IRIBAS CM, BINGHAM S, KHAW KT, WAREHAM N, KEY T, RODDAM A, TRICHOPOULOU A, BENETOU V, TRICHOPOULOS D, MASALA G, SIERI S, TUMINO R, SACERDOTE C, MATTIELLO A, VERSCHUREN WM, BUENO DE MESQUITA HB, GROBBEE DE, VAN DER SCHOUW YT, MELANDER O, HALLMANS G, WENNBERG P, LUND E, KUMLE M, SKEIE G, FERRARI P, SLIMANI N, NORAT T, RIBOLI E., PANICO, SALVATORE, Danesh, J, Saracci, R, Berglund, G, Feskens, E, Overvad, K, Panico, Salvatore, Thompson, S, Fournier, A, CLAVEL CHAPELON, F, Canonico, M, Kaaks, R, Linseisen, J, Boeing, H, Pischon, T, Weikert, C, Olsen, A, Tjonneland, A, Johnsen, Sp, Jensen, Mk, Quiros, Jr, Svatetz, Ca, Perez, Mj, Larranaga, N, Sanchez, Cn, Iribas, Cm, Bingham, S, Khaw, Kt, Wareham, N, Key, T, Roddam, A, Trichopoulou, A, Benetou, V, Trichopoulos, D, Masala, G, Sieri, S, Tumino, R, Sacerdote, C, Mattiello, A, Verschuren, Wm, BUENO DE MESQUITA, Hb, Grobbee, De, VAN DER SCHOUW, Yt, Melander, O, Hallmans, G, Wennberg, P, Lund, E, Kumle, M, Skeie, G, Ferrari, P, Slimani, N, Norat, T, and Riboli, E.
- Published
- 2007
12. A balance between activating and repressive histone modifications regulates cystic fibrosis transmembrane conductance regulator (CFTR) expression in vivo
- Author
-
Bergougnoux A, Rivals I, Liquori A, Raynal C, Varilh J, Magalhães M, Perez MJ, Bigi N, Des Georges M, Chiron R, Squalli-Houssaini AS, Claustres M, and De Sario A
- Subjects
cystic fibrosis ,promoter ,DNA methylation ,histone modifications ,bivalent chromatin ,enhancers ,fetal tissues - Abstract
The genetic mechanisms that regulate CFTR, the gene responsible for cystic fibrosis, have been widely investigated in cultured cells. However, mechanisms responsible for tissue-specific and time-specific expression are not completely elucidated in vivo. Through the survey of public databases, we found that the promoter of CFTR was associated with bivalent chromatin in human embryonic stem (ES) cells. In this work, we analyzed fetal (at different stages of pregnancy) and adult tissues and showed that, in digestive and lung tissues, which expressed CFTR, H3K4me3 was maintained in the promoter. Histone acetylation was high in the promoter and in two intronic enhancers, especially in fetal tissues. In contrast, in blood cells, which did not express CFTR, the bivalent chromatin was resolved (the promoter was labeled by the silencing mark H3K27me3). Cis-regulatory sequences were associated with lowly acetylated histones. We also provide evidence that the tissue-specific expression of CFTR is not regulated by dynamic changes of DNA methylation in the promoter. Overall, this work shows that a balance between activating and repressive histone modifications in the promoter and intronic enhancers results in the fine regulation of CFTR expression during development, thereby ensuring tissue specificity.
- Published
- 2014
13. Physical activity reduces the risk of incident type 2 diabetes in general and in abdominally lean and obese men and women: the EPIC-InterAct Study
- Author
-
Ekelund, U, Palla, L, Brage, S, Franks, PW, Peters, T, Balkau, B, Diaz, MJT, Huerta, JM, Agnoli, C, Arriola, L, Ardanaz, E, Boeing, H, Clavel-Chapelon, F, Crowe, F, Fagherazzi, G, Groop, L, Hainaut, P, Johnsen, NF, Kaaks, R, Khaw, KT, Key, TJ, de Lauzon-Guillain, B, May, A, Monninkhof, E, Navarro, C, Nilsson, P, Ostergaard, JN, Norat, T, Overvad, K, Palli, D, Panico, S, Redondo, ML, Ricceri, F, Rolandsson, O, Romaguera, D, Romieu, I, Sanchez Perez, MJ, Slimani, N, Spijkerman, A, Teucher, B, Tjonneland, A, Travier, N, Tumino, R, Vos, W, Vigl, M, Sharp, S, Langenberg, C, Forouhi, N, Riboli, E, Feskens, E, Wareham, NJ, and Consortium, I
- Subjects
Male ,Nutrition and Disease ,Endocrinology, Diabetes and Metabolism ,body-mass index ,Type 2 diabetes ,Body Mass Index ,Cohort Studies ,Risk Factors ,Surveys and Questionnaires ,Voeding en Ziekte ,Abdominal obesity ,adiposity ,Incidence ,improves ,Middle Aged ,10 european countries ,Europe ,fat distribution ,Cohort ,Female ,Waist Circumference ,medicine.symptom ,medicine.medical_specialty ,Waist ,life-style ,Motor Activity ,Article ,Internal medicine ,Diabetes mellitus ,Internal Medicine ,medicine ,accelerometry ,Humans ,insulin sensitivity ,Case–cohort study ,Genetic Predisposition to Disease ,Obesity ,heart-rate ,Life Style ,VLAG ,Physical activity ,business.industry ,medicine.disease ,Physical activity level ,Diabetes Mellitus, Type 2 ,Incident diabetes ,Physical therapy ,business ,Body mass index ,Follow-Up Studies ,mellitus - Abstract
Aims/hypothesis We examined the independent and combined associations of physical activity and obesity with incident type 2 diabetes in men and women. Methods The InterAct case–cohort study consists of 12,403 incident type 2 diabetes cases and a randomly selected subcohort of 16,154 individuals, drawn from a total cohort of 340,234 participants with 3.99 million person-years of follow-up. Physical activity was assessed by a four-category index. Obesity was measured by BMI and waist circumference (WC). Associations between physical activity, obesity and case-ascertained incident type 2 diabetes were analysed by Cox regression after adjusting for educational level, smoking status, alcohol consumption and energy intake. In combined analyses, individuals were stratified according to physical activity level, BMI and WC. Results A one-category difference in physical activity (equivalent to approximately 460 and 365 kJ/day in men and women, respectively) was independently associated with a 13% (HR 0.87, 95% CI 0.80, 0.94) and 7% (HR 0.93, 95% CI 0.89, 0.98) relative reduction in the risk of type 2 diabetes in men and women, respectively. Lower levels of physical activity were associated with an increased risk of diabetes across all strata of BMI. Comparing inactive with active individuals, the HRs were 1.44 (95% CI 1.11, 1.87) and 1.38 (95% CI 1.17, 1.62) in abdominally lean and obese inactive men, respectively, and 1.57 (95% CI 1.19, 2.07) and 1.19 (95% CI 1.01, 1.39) in abdominally lean and obese inactive women, respectively. Conclusions/interpretation Physical activity is associated with a reduction in the risk of developing type 2 diabetes across BMI categories in men and women, as well as in abdominally lean and obese men and women. Electronic supplementary material The online version of this article (doi:10.1007/s00125-012-2532-2) contains peer-reviewed but unedited supplementary material, which is available to authorised users.
- Published
- 2012
- Full Text
- View/download PDF
14. Plasma carotenoids as biomarkers of intake of fruits and vegetables: individual-level correlations in the European Prospective Investigation into Cancer and Nutrition (EPIC)
- Author
-
Al-Delaimy, WK Ferrari, P Slimani, N Pala, V Johansson, I Nilsson, S Mattisson, I Wirfalt, E Galasso, R and Palli, D Vineis, P Tumino, R Dorronsoro, M Pera, G and Ocke, MC Bueno-de-Mesquita, HB Overvad, K Chirlaque, MAD and Trichopoulou, A Naska, A Tjonneland, A Olsen, A Lund, E and Alsaker, EHR Barricarte, A Kesse, E Boutron-Ruault, MC and Clavel-Chapelon, F Key, TJ Spencer, E Bingham, S and Welch, AA Sanchez-Perez, MJ Nagel, G Linseisen, J and Quiros, JR Peeters, PHM van Gils, CH Boeing, H van Kappel, AL Steghens, JP Riboli, E
- Subjects
food and beverages - Abstract
Objective: The aim in this study was to assess the association between individual plasma carotenoid levels (alpha-carotene, beta-carotene, lycopene, beta-cryptoxanthin, lutein, zeaxanthin) and fruit and vegetable intakes recorded by a calibrated food questionnaire (FQ) and 24- h dietary recall records (24HDR) in nine different European countries with diverse populations and widely varying intakes of plant foods. Design: A stratified random subsample of 3089 men and women from nine countries participating in the European Prospective Investigation into Cancer and Nutrition (EPIC), who had provided blood samples and dietary and other lifestyle information between 1992 and 2000, were included. Results: beta-Cryptoxanthin was most strongly correlated with total fruits (FQ r = 0.52, 24HDR r = 0.39), lycopene with tomato and tomato products (FQ r = 0.38, 24HDR r = 0.25), and alpha-carotene with intake of root vegetables (r = 0.39) and of total carrots (r = 0.38) for FQ only. Based on diet measured by FQ and adjusting for possible confounding by body mass index (BMI), age, gender, smoking status, alcohol intake, and energy intake, the strongest predictors of individual plasma carotenoid levels were fruits (R-partial(2) = 17.2%) for beta-cryptoxanthin, total carrots (R-partial(2) = 13.4%) and root vegetables (R-partial(2) = 13.3%) for alpha-carotene, and tomato products (R-partial(2) = 13.8%) for lycopene. For 24HDR, the highest R-partial(2) was for fruits in relation to beta-cryptoxanthin (7.9%). Conclusions: Intakes of specific fruits and vegetables as measured by food questionnaires are good predictors of certain individual plasma carotenoid levels in our multicentre European study. At individual subject levels, FQ measurements of fruits, root vegetables and carrots, and tomato products are, respectively, good predictors of beta-cryptoxanthin, alpha-carotene, and lycopene in plasma.
- Published
- 2005
15. Indications and contraindications of dental implants in medically compromised patients: Update
- Author
-
Gomez-de Diego, R., primary, Mang-de la Rosa, M., additional, Romero-Perez, MJ., additional, Cutando-Soriano, A., additional, and Lopez-Valverde-Centeno, A., additional
- Published
- 2014
- Full Text
- View/download PDF
16. Implants in disabled patients: A review and update
- Author
-
Romero-Perez, MJ., primary, Mang-de la Rosa, M., additional, Lopez-Jimenez, J., additional, Fernandez-Feijoo, J., additional, and Cutando-Soriano, A., additional
- Published
- 2014
- Full Text
- View/download PDF
17. The bacteremia of dental origin and its implications in the appearance of bacterial endocarditis
- Author
-
Mang-de la Rosa, MR., primary, Castellanos-Cosano, L., additional, Romero-Perez, MJ., additional, and Cutando, A., additional
- Published
- 2014
- Full Text
- View/download PDF
18. Plasma carotenoids as biomarkers of intake of fruits and vegetables : individual-level correlations in the European Prospective Investigation into Cancer and Nutrition (EPIC).
- Author
-
Al-Delaimy, WK, Ferrari, P, Slimani, N, Pala, V, Johansson, Ingegerd, Nilsson, S, Mattisson, I, Wirfalt, E, Galasso, R, Palli, D, Vineis, P, Tumino, R, Dorronsoro, M, Pera, G, Ocké, MC, Bueno-de-Mesquita, HB, Overvad, K, Chirlaque, M, Trichopoulou, A, Naska, A, Tjonneland, A, Olsen, A, Lund, E, Alsaker, EH, Barricarte, A, Kesse, E, Boutron-Ruault, MC, Clavel-Chapelon, F, Key, TJ, Spencer, E, Bingham, S, Welch, AA, Sanchez-Perez, MJ, Nagel, G, Linseisen, J, Quirós, JR, Peeters, PH, van Gils, CH, Boeing, H, van Kappel, AL, Steghens, JP, Riboli, E, Al-Delaimy, WK, Ferrari, P, Slimani, N, Pala, V, Johansson, Ingegerd, Nilsson, S, Mattisson, I, Wirfalt, E, Galasso, R, Palli, D, Vineis, P, Tumino, R, Dorronsoro, M, Pera, G, Ocké, MC, Bueno-de-Mesquita, HB, Overvad, K, Chirlaque, M, Trichopoulou, A, Naska, A, Tjonneland, A, Olsen, A, Lund, E, Alsaker, EH, Barricarte, A, Kesse, E, Boutron-Ruault, MC, Clavel-Chapelon, F, Key, TJ, Spencer, E, Bingham, S, Welch, AA, Sanchez-Perez, MJ, Nagel, G, Linseisen, J, Quirós, JR, Peeters, PH, van Gils, CH, Boeing, H, van Kappel, AL, Steghens, JP, and Riboli, E
- Abstract
OBJECTIVE: The aim in this study was to assess the association between individual plasma carotenoid levels (alpha-carotene, beta-carotene, lycopene, beta-cryptoxanthin, lutein, zeaxanthin) and fruit and vegetable intakes recorded by a calibrated food questionnaire (FQ) and 24-h dietary recall records (24HDR) in nine different European countries with diverse populations and widely varying intakes of plant foods. DESIGN: A stratified random subsample of 3089 men and women from nine countries participating in the European Prospective Investigation into Cancer and Nutrition (EPIC), who had provided blood samples and dietary and other lifestyle information between 1992 and 2000, were included. RESULTS: beta-Cryptoxanthin was most strongly correlated with total fruits (FQ r = 0.52, 24HDR r = 0.39), lycopene with tomato and tomato products (FQ r = 0.38, 24HDR r = 0.25), and alpha-carotene with intake of root vegetables (r = 0.39) and of total carrots (r = 0.38) for FQ only. Based on diet measured by FQ and adjusting for possible confounding by body mass index (BMI), age, gender, smoking status, alcohol intake, and energy intake, the strongest predictors of individual plasma carotenoid levels were fruits (R(partial)(2) = 17.2%) for beta-cryptoxanthin, total carrots ((partial)(2) = 13.4%) and root vegetables (R(partial)(2) = 13.3%) for alpha-carotene, and tomato products (R(partial)(2) = 13.8%) for lycopene. For 24HDR, the highest R(partial)(2) was for fruits in relation to beta-cryptoxanthin (7.9%). CONCLUSIONS: Intakes of specific fruits and vegetables as measured by food questionnaires are good predictors of certain individual plasma carotenoid levels in our multicentre European study. At individual subject levels, FQ measurements of fruits, root vegetables and carrots, and tomato products are, respectively, good predictors of beta-cryptoxanthin, alpha-carotene, and lycopene in plasma.
- Published
- 2005
- Full Text
- View/download PDF
19. Looking for a Guideline in Non-Surgical Therapy of the Periodontal Disease assisted laser: A Review
- Author
-
Perez, MJ, primary, Aguilo, L, additional, Bisheimer, M, additional, and Saez, I., additional
- Published
- 2012
- Full Text
- View/download PDF
20. Mitochondrial genome depletion dysregulates bile acid- and paracetamol-induced expression of the transporters Mdr1, Mrp1 and Mrp4 in liver cells
- Author
-
Perez, MJ, primary, Gonzalez-Sanchez, E, additional, Gonzalez-Loyola, A, additional, Gonzalez-Buitrago, JM, additional, and Marin, JJG, additional
- Published
- 2011
- Full Text
- View/download PDF
21. CARDIO-PROTECTIVE, ANTI-THROMBOTIC MEDICATION AND SURVIVAL IN VASCULAR ACCESS FOR HEMODIALYSIS: PP.15.75
- Author
-
Benitez Sanchez, M, primary, Gonzalez Carmelo, I, additional, Moreno Sanchez, T, additional, Lozano, A, additional, Moreno Rodriguez, F, additional, Cruz Mu&;ntilde;oz, S, additional, Rodriguez Gomez, E, additional, Fernandez Mora, F, additional, Merino Perez, MJ, additional, and Suarez Rodriguez, C, additional
- Published
- 2010
- Full Text
- View/download PDF
22. Presence of a lethal protease in the extracellular products of Vibrio splendidus?Vibrio lentus related strains
- Author
-
Farto, R, primary, Armada, SP, additional, Montes, M, additional, Perez, MJ, additional, and Nieto, TP, additional
- Published
- 2006
- Full Text
- View/download PDF
23. ELECTROPORACIÓN IRREVERSIBLE: AMPLIANDO LAS FRONTERAS DE LA ABLACIÓN
- Author
-
Alonso-González, R., Abadal Villayandre, JM., Gálvez Gonzalez, E., Álvarez Perez, MJ, Méndez Alonso, S., and de Gregorio Ariza, MA
- Abstract
La electroporación irreversible o IRE (Irreversible Electroporation) es una técnica de ablación tumoral no térmica basada en la aplicación de pulsos eléctricos de alto voltaje entre pares de agujas insertadas alrededor de un tumor. La corriente generada favorece la creación de nanoporos en la membrana plasmática, desencadenando la apoptosis. Por ello, la IRE puede utilizarse de manera segura en localizaciones cercanas a estructuras vasculares delicadas, contraindicadas para el resto de técnicas termoablativas.
- Published
- 2023
- Full Text
- View/download PDF
24. Hepatitis and human immunodeficiency virus co-infection among injection drug users in Los Angeles County, California.
- Author
-
Fisher DG, Reynolds GL, Jaffe A, and Perez MJ
- Abstract
This study examined the prevalence of hepatitis A (HAV), B (HBV), C (HCV), and Human Immunodeficiency Virus (HIV) co-infection among Injection Drug Users (IDUs) in Los Angeles County, California, and predictors of multiple infections in this population. Six hundred seventy-nine IDUs were recruited from October 2002 through June 2004. Participants completed questionnaires to elicit demographic, drug and sex risk information, and were tested for hepatitis A, B, C and HIV.A linear regression model predicting the total number of infections (0 to 4 possible) was constructed. Significant associations were found between HAV and HBV infection, HAV and HCV infection, and HBV and HCV infection. Predictors of total co-infections included age of first injection, lifetime years in jail, and Hispanic ethnicity. Latinos had the highest proportion of HAV and HBV co-infection with HCV. The total number of co-infections, especially those co-infected with all three of the hepatitis infections, was unexpectedly high. [ABSTRACT FROM AUTHOR]
- Published
- 2006
- Full Text
- View/download PDF
25. Balloon atrial septostomy is associated with preoperative stroke in neonates with transposition of the great arteries.
- Author
-
McQuillen PS, Hamrick SE, Perez MJ, Barkovich AJ, Glidden DV, Karl TR, Teitel D, and Miller SP
- Published
- 2006
26. Autoregulation of cerebral blood flow and its relation to cerebrospinal fluid pH
- Author
-
Hernandez-Perez, MJ, primary and Anderson, DK, additional
- Published
- 1976
- Full Text
- View/download PDF
27. Poster session 6
- Author
-
Lofmark, H, Winter, R, Moukarzel, JA, Filipuzzi, JM, Vaisbuj, F, Salmo, F, Guevara, E, Barbier, P, Savioli, G, Keramida, K, Kouris, N, Dawson, D, Olympios, CD, Nihoyannopoulos, P, Meel, R, Peters, F, Libhaber, E, Nel, S, Goncalves, R, Essop, MR, Dinis, P G, Teixeira, R, Madeira, M, Cachulo, MC, Goncalves, L, Jorstig, S, Emilsson, K, Waldenborg, M, Liden, M, Wodecki, M, Thunberg, P, Perez, Valverde, Sotelo, J, Beerbaum, P, Grotenhuis, H, Greil, G, Razavi, R, Uribe, S, Figueroa, A, Zemedkun, M, Wang, Z, Asch, FM, Gizzi, G, Fabiani, D, Lavorgna, A, Napoletano, C, Saha, S K, Muthukumar, L, Englund, E, Toole, R, Gopal, AS, Di Salvo, G, Issa, Z, Moiduddin, N, Siblini, G, Bulbul, Z, Yurdakul, SELEN, Ercan, G, Tekkesin, ILKER, Sahin, ST, Cengiz, B, Celik, G, Demircan, SABRI, Aytekin, SAIDE, Chumarnaya, T, Alueva, Y, Kochmasheva, VV, Solovyova, O, Tuset, L, Maceira Gonzalez, A M, Igual, B, Bruin De- Bon, HACM, Cocchieri, R, Wagner, GS, Eberl, S, Brink Van Den, RBA, Bouma, BJ, Onishi, T, Kawai, H, Tanaka, H, Fujiwara, S, Hirata, K, Marketou, M, Parthenakis, F, Kontaraki, J, Patrianakos, A, Nakou, H, Maragkoudakis, S, Vougia, D, Logakis, J, Roufas, K, Vardas, P, Bayuga, MT, Ramboyong, RE, Johansson, M C, Wallentin Guron, C, Thurin, A, Wessling, N, Almodares, Q, Fu, M, Mandour Ali, M, Mohamed, LA, Abd Al-Rahman, T, Maghraby, HM, Kora, IM, Abdel-Hameed, FR, Ali, MN, King, GJ, Byrne, D, Bennett, K, Norris, K, Daly, C, Murphy, RT, Marti, G, Degiovanni, A, Di Ruocco, MV, Sartori, C, Devecchi, P, Marino, P, Angelis, A, Aggeli, K, Ioakeimidis, N, Felekos, I, Aznaouridis, K, Rokas, K, Abdelrasoul, M, Terentes, D, Vlachopoulos, C, Tousoulis, D, Spinelli, L, Stabile, E, Santoro, M, Morisco, C, Giudice, C A, Esposito, G, Trimarco, B, Dragoi Galrinho, R, Ciobanu, AO, Rimbas, RC, Manole, GC, Marinescu, B, Vinereanu, D, Krljanac, G, Trifunovic, D, Savic, L, Asanin, M, Lasica, R, Aleksandric, S, Zlatic, N, Petrovic, M, Jovanovic, LJ, Mrdovic, I, Zahidova, K, aethiology, Chronic heart failure of ishemic, anemia, Trifunovic, D, Krljanac, G, Sobic Saranovic, D, Asanin, M, Grozdic Milojevic, I, Savic, L, Vasiljevic, Z, Aleksandric, S, Srdic, M, Mrdovic, I, Mateescu, AD, Calin, A, Rosca, M, Beladan, CC, Enache, R, Gurzun, MM, Varga, P, Calin, C, Ginghina, C, Popescu, BA, Melissopoulou, M, Nguyen, V, Mathieu, T, Attias, D, Dreyfus, J, Codogno, I, Vahanian, A, Messika-Zeitoun, D, study, The COFRASA/GENERAC, Stefanidis, A, Komatanou, E, Anagnostou, E, Armatas, G, Samiotou, D, Papaspyropoulos, A, Philippou, P, Korlou, P, Tzerefos, S, Kranidis, A, Kammerer, I, Wiedemann, M, Sack, FU, Koyama, T, Fukuhara, K, Imai, K, Yamada, R, Kume, T, Neishi, Y, Uemura, S, Pergola, V, Di Salvo, G, Fadel, B, Aladmawi, M, Shahid, M, Alamri, M, Bulbul, Z, Issa, Z, Alhalees, Z, Rafael De La Espriella Juan, RDLE, Rafael Paya-Serrano, RPS, Jose-Leando Perez-Bosca, JLPB, Francisco Ridocci-Soriano, FRS, Oscar Fabregat-Andres, OFA, Cristina Albiach-Montanana, CAM, Natalia Chacon-Hernandez, NCH, Laura Higueras-Ortega, LHO, Blanca Trejo-Velasco, BTV, Salvador Morell-Cabedo, SMC, Bech-Hanssen, O, Polte, CL, Johnsson, AA, Cederbom, U, Lagerstrand, K, Gao, SA, Cho, E J, Hwang, J W, Park, S J, Yun, H R, Lee, S C, Park, S W, Poilane, M, Cueff, C, Jaafar, P, Jobbe Duval, A, Guijarro, D, Le Tourneau, T, Vaturi, M, Kotler, T, Shapira, Y, Weisenberg, D, Monakier, D, Kazum, S, Sagie, A, Valuckiene, Z, Ovsianas, J, Jurgaityte, J, Jasiskyte, V, Jurkevicius, R, Jenei, C, Muraru, D, Aruta, P, Miglioranza, M H, Cavalli, G, Romeo, G, Peluso, D, Cucchini, U, Iliceto, S, Badano, L P, Yesin, M, Kalcik, M, Gursoy, MO, Gunduz, S, Astarcioglu, MA, Karakoyun, S, Bayam, E, Cersit, S, Ozkan, M, Galuszka, O M, Reinthaler, M, Rutschow, S, Gross, M, Landmesser, U, Kasner, M, Caggegi, A M, Scandura, S, Capranzano, P, Mangiafico, S, Ronsivalle, G, Cannata, S, Farruggio, S, Giaquinta, S, Grasso, C, Tamburino, C, Merchan Cuenda, M, Fuentes Canamero, M E, Bengla Limpo, B, Chacon Pinero, A, Millan Nunez, M V, Nogales Asensio, JM, Lopez Minguez, J R, Garcia Corrales, C, Aranda Lopez, C, Merchan Herrera, A, Merchan Cuenda, M, Fuentes Canamero, M E, Bengla Limpo, B, Millan Nunez, M V, Nogales Asensio, J M, Lopez Minguez, J R, Chacon Pinero, A, Marquez Lozano, P, Garcia Corrales, C, Merchan Herrera, A, Lo Presti, M, Polizzi, V, Pino, GP, Luzi, G, Fiorilli, R, Pergolini, A, Madeo, A, Malouf, J, Buffa, V, Musumeci, F, Islas, F, Almeria, C, Olmos, C, Garcia, E, Nombela, L, De Agustin, JA, Marcos-Alberca, P, Mahia, P, Macaya, C, Perez De Isla, L, Pontes Dos Santos, R A, Correia, E, Cruz, I, Reis, L, Oliveira, M, Faria, R, Magalhaes, P, Domingues, K, Picarra, B, Marques, N, Nemes, A, Domsik, P, Kalapos, A, Sepp, R, Foldeak, D, Borbenyi, Z, Forster, T, Masiha, S, Reis, L, Teixeira, R, Caetano, F, Almeida, I, Trigo, J, Botelho, A, Silva, J, Nascimento, J, Goncalves, L, Cubero Gallego, H, Dobarro Perez, D, Diez De Las Heras, D, Llerena Butron, S, Tobar Ruiz, J, Martin Morquecho, I, Arnold, R, San Roman Calvar, JA, De Gregorio, C, Ando', G, Dattilo, G, Trio, O, Cusma' Piccione, M, Zito, C, Nicotera, A, D'angelo, M, Carerj, S, Ziolkowska, L, Spiewak, M, Malek, L, Boruc, A, Kawalec, W, Alvarez-Ortega, C A, Gonzalez Fernandez, O, Refoyo Salicio, E, Mori, R, Peinado Peinado, R, Lago, M, Trigo, E, Lopez-Sedon, JL, Yuan, L, Zhang, XX, Xie, MX, Jin, XY, Hospital, Union, College, Tongji Medical, Science, Huazhong University of, Technology, Ultrasonography, Department of, Leao, S, Bento, D, Lourenco, C, Domingues, K, Almeida, AR, Marmelo, B, Picarra, B, Lima, R, Faria, R, Azevedo, O, Accadia, M, Irace, L, Abitabile, M, Iengo, R, Arnese, MR, Cocchia, R, Scotto Di Uccio, F, Spadaro, P, Tuccillo, A, Tuccillo, B, Budnik, M, Piatkowski, R, Kochanowski, J, Gaska, M, Glowacka, P, Karolczak, P, Ochijewicz, D, Opolski, G, Stevanovic, A, Dekleva, M, Tsai, W-C, Yang, L-T, Liu, Y-W, Abusalma, Y, O'connell, E, Kenny, C, Mcdonald, K, Mohamed Fereig Hamed, H, Hafez, EMAN, Habib, SHIMAA, Peluso, D, Pigatto, E, Romeo, G, Cucchini, U, Muraru, D, Aruta, P, Cozzi, F, Punzi, L, Iliceto, S, Badano, LP, Podoleanu, C, Coman, I, Jeremias, ZS, Varga, A, Tarta, C, Grancea, I, Tarusi, M, Frigy, A, Carasca, E, Doronzo, A, Piazza, R, Neglia, L, Cervesato, E, Nicolosi, GL, Cassin, M, Upton, R, Aye, C, Davis, E, Packham, A, Arnold, L, Kenworthy, Y, Lamata, P, Lewandowski, A, Leeson, P, Abuladze, GA, Jinjolia, NJ, Ribeiro, JM, Teixeira, R, Fernandes, A, Cassandra, M, Pinto, H, Marques, MG, Raposo, H, Carreira, A, Campos, M, Goncalves, L, De La Chica, JA, Ortiz Garrido, A, Cuenca, V, Conejo, L, Zabala, I, De Mora, M, Petruzzelli, MF, Vasti, MP, Scali, MC, Tramacere, F, D'errico, MP, Gianicolo, EAL, Andreassi, MG, Picano, E, Portaluri, M, Ferrera Duran, C, Gomez-Escalonilla, C, De Agustin, JA, Egido, J, Almeria, C, Simal, P, Marcos, P, Rodrigo, JL, Macaya, C, Perez De Isla, L, Tomaszewski, M, Brzozowski, W, Tomaszewski, A, Poterala, M, Diaz-Pelaez, E, Marciniak, A, Gargallo-Fernandez, P, Barrio-Rodriguez, A, Araco, M, Sharma, R, Wierzbowska-Drabik, K, Kasprzak, JD, Wierzbowska-Drabik, K, Kasprzak, JD, Velasco Del Castillo, S, Anton Ladislao, A, Cacicedo Fernandez Bobadilla, A, Onandia Gandarias, JJ, Sainz, S, Gomez Sanchez, V, Rodriguez Sanchez, I, Garcia Cuenca, E, Zugazabeitia Irazabal, G, Generati, G, Bandera, F, Pellegrino, M, Carbone, F, Labate, V, Alfonzetti, E, Villani, S, Gaeta, M, Ferraro, O, Guazzi, M, Zaborska, B, Smarz, K, Pilichowska-Paszkiet, E, Sikora-Frac, M, Budaj, A, De Diego Soler, O, Ferrer Sistach, E, Vallejo Camazon, N, Lopez-Ayerbe, J, Teis Soley, A, Gual Capllonch, F, Serrano Garcia, S, Bernal Labrador, E, Junca Puig, G, Bayes-Genis, A, Merchan-Gomez, S, Garcia-Sanchez, MJ, Barreiro-Perez, MJ, Arribas-Jimenez, A, Sanchez-Corral, E, Cruz-Gonzalez, I, Martin-Leal, LI, Gajate-Herrero, D, Perdiguero-Martin, PL, Sanchez-Fernandez, PL, Lee, M, Jang, YJ, Lee, YJ, Kim, YS, Chun, WJ, Kang, GH, Oh, JH, Aquila, I, Hinojar, R, Fernandez-Golfin, C, Gonzalez, A, Rincon, LM, Casas, E, Ruiz, S, Barrios, V, Jimenez-Nacher, JJ, Zamorano, JL, Necas, J, Kovalova, S, Perea, GO, Lombardero, M, Henquin, R, Tinetti, M, Corneli, M, Sotaquira, Miguel, Cairati, Mattia, Ettorre, Alessandro, Pepi, Mauro, Tamborini, Gloria, Caiani, Enrico, Sanchez-Martinez, S, Duchateau, N, Erdei, T, Fraser, A, Piella, G, Bijnens, B H, Nestaas, E, Stoylen, A, Fugelseth, D, Hinojar, R, Fernandez-Golfin, C, Esteban, A, Gonzalez-Gomez, A, Garcia-Martin, A, Casas Rojo, E, Pascual-Izco, M, Jimenez-Nacher, JJ, Zamorano, JL, Cerne, A, Berden, P, Agelaki, M, Sundar, S, Antonakaki, D, Grapsa, J, Dawson, D, Papadopoulos, C, Katsivas, A, Nihoyannopoulos, P, Sanchis Ruiz, L, Sanz, M, Bijnens, B, Giraldeau, G, Grazioli, G, Marin, M, Montserrat, S, Sitges, M, Cambronero Cortinas, E, Grapsa, J, Dawson, D, Howard, L, Gin-Sing, W, Valle, A, Corbi-Pascual, MJ, Saez-Mendez, L, Gibbs, S, Nihoyannopoulos, P, Grue, J F, Storve, S, Mjoelstad, O C, Samstad, S O, Dalen, H, Torp, H, Haugen, B O, Yim, D, Mertens, L, Friedberg, MK, Grosse-Wortmann, L, Dragulescu, A, Djikic, DDJ, Simic, SD, Peric, VP, Mujovic, NM, Jankovic, NJ, Marinkovic, MM, Martinez Santos, P, Batlle Lopez, E, Vilacosta, I, Sanchez Sauce, B, De La Rosa Riestra, A, Alonso Bello, J, Espana Barrio, E, Jimenez Valtierra, J, Campuzano Ruiz, R, Rios, Martin, Vrsalovic, M, Hummel, SL, Ghanbari, H, Alpert, C, Oral, H, Kolias, TJ, Mghaieth Zghal, F, Jabberi, Z, Rekik, B, Boudiche, S, Aloui, H, Ben Hlima, M, Ouali, S, Larbi, N, Mourali, MS, Nemes, A, Marton, I, Domsik, P, Kalapos, A, Posfai, E, Modok, S, Borbenyi, Z, Forster, T, Maceira Gonzalez, A M, Monmeneu, JV, Igual, B, Lopez Lereu, MP, Garcia, P, Cosin Sales, J, Maceira Gonzalez, A M, Igual, B, Monmeneu, JV, Lopez Lereu, P, Garcia, MP, Cosin Sales, J, Bala, G, Baudhuin, H, Gillis, K, Remory, I, Krasniqi, A, Lahoutte, T, Devoogdt, N, Droogmans, S, Cosyns, B, Hernot, S, Bulugahapitiya, D S, Bebb, O, Moustafa, A, Vilades, D, Colom Comi, C, Perez-Perez, A, Carreras, F, Leta, R, Pons, G, Jinjolia, NJ, and Abuladze, GA
- Abstract
Purpose: To explore the cost effectiveness of expert hand-held echo (HHE) upstream as an alternative to referral for a complete transthoracic echo (TTE) in clinical routine. We hypothized that an upstream HHE approach would prove adequate and cost effective in terms of - Decrease the numbers of required TTE - Fewer revisits to the outpatient unit - Shorten the length of admission - Increase the number of higly specialized echoes, i.e. stress echo, transesophageal echoes - Shorten the time to final diagnosis and decrease the concerns for the patient who is forced to wait for survey and results at complete TTE. Methods: In this study, a HHE scanner (V-scan, GE Health care) was kept available for the senior consultants with level 3 TTE certification, for use in patients where a TTE was indicated. HHE was performed in different clinical scenarios such in the emergency room, during consultation of inpatients or in the clinic of outpatients. The results of HHE was documented in the patient record under a heading and can directly be found upon request. The length of hospital stay during a representative week, is compared between patients who have not undergone HHE with patients undergoing HHE. Results: Out of a total of 94 patients examined with HHE, 71 patients were not in need of a complete TTE. Additional 11 patients received a more rapid investigation i.e stress-echo, transesophageal echocardiography or other investigations that would otherwise have been delayed because of waiting for the complete TTE. 12 patients were in need of a complete TTE for a more precise analysis. In the heart clinic of Danderyds hospital approximately 18 inpatients were examined with a complete TTE every ordinary week and that postpone the day of submission from hospital among approximately 6 patients a week. Every day of care in hospital cost 445 € in an ordinary ward and 981 € in the heart intensive care unit. This means there is a cost benefit of approximately 3741 € every week if it is possible to prevent this postponing of submission. Conclusions: Upstream HHE in clinical routine was in the setting of this study highly cost-effective, decreasing the need of TTE to a great extent, and leading to quicker diagnosis, shorter hospital stays and less anxiety in patients during the waiting time for a complete TTE and before a response is received.
- Published
- 2015
- Full Text
- View/download PDF
28. Prevalence and timing of pregnancy termination for brain malformations.
- Author
-
Rouleau C, Gasner A, Bigi N, Couture A, Perez MJ, Blanchet P, Faure JM, Rivier F, Boulot P, Laquerrière A, Encha-Razavi F, Rouleau, Caroline, Gasner, Adeline, Bigi, Nicole, Couture, Alain, Perez, Marie Josée, Blanchet, Patricia, Faure, Jean Michel, Rivier, François, and Boulot, Pierre
- Abstract
Objective: To determine the prevalence and the timing of pregnancy termination relative to the type of central nervous system (CNS) malformations. Design Retrospective cohort study.Setting: Multidisciplinary centre for prenatal diagnosis in the Languedoc-Roussillon region, France.Population: A cohort of 481 pregnancy terminations performed between 2005 and 2009.Methods: Detailed post-termination fetal and neuropathological analyses were carried out to identify the CNS malformations. Then, the prevalence and timing of pregnancy termination were assessed relative to the identified malformations.Results: About one-third of pregnancy terminations (143/481) were performed for severe CNS malformations. Up to 24 weeks of gestation (WG), pregnancy terminations (56.6%) were carried out mainly for defects occurring during the two major first steps of CNS development (neurulation and differentiation of cerebral vesicles). After 24 WG, pregnancy terminations (43.3%) were mainly performed for corpus callosum agenesis (16/17), vermian agenesis (10/12) and gyral anomalies (13/15). For hindbrain malformations and gyral anomalies, there was a significant relationship between the timing of pregnancy termination and the presence of a severe ventriculomegaly at prenatal diagnosis (p=0.002 and p=0.02, respectively).Conclusion: By classifying CNS malformations according to the neuropathological analysis, the authors show that the timing and prevalence of pregnancy termination are distributed in a manner that is consistent with what is currently known on the development of brain. They are also influenced by the French prenatal screening policy and the variable expressivity of the brain malformations and associated lesions. [ABSTRACT FROM AUTHOR]- Published
- 2011
- Full Text
- View/download PDF
29. Decreased full breastfeeding, altered practices, perceptions, and infant weight change of prepregnant obese women: a need for extra support.
- Author
-
Mok E, Multon C, Piguel L, Barroso E, Goua V, Christin P, Perez MJ, and Hankard R
- Published
- 2008
- Full Text
- View/download PDF
30. Acquisition of viable-like surface properties of sperm cells by adsorption of seminal plasma proteins revealed by centrifugal countercurrent distribution
- Author
-
Pascual, ML, Muiño-Blanco, T, Cebrián-Pérez, JA, and López-Pérez, MJ
- Published
- 1994
- Full Text
- View/download PDF
31. The evolving microbiome from pregnancy to early infancy: A comprehensive review
- Author
-
Jordi Clotet, Begoña Loureiro, Mª Jesús Cabero Perez, Elisa Llurba Olivé, Maria José Solana, Myriam Perez Gruz, Miguel Saenz de Pipaon, Elvira Larqué Daza, Talía Sainz, Sergi Fernandez Gonzalez, Isabel Iglesias-Platas, Vicente Andreu-Fernández, Anna Parra-Llorca, Gerardo Martínez, Jesús López-Herce, Leopoldo Martinez, María Gormaz, Iris Iglesia, Sebastian Sailer, Fernando Cabañas, Máximo Vento, María D. Mesa, Dolores Gómez Roig, Oscar García Algar, Diana Escuder-Vieco, Carmen Rosa Pallás-Alonso, Cristina Calvo, María Sánchez-Campillo, Rosa Aras, UAM. Departamento de Pediatría, UAM. Departamento de Farmacología, Instituto de Investigación Sanitaria Hospital Universitario de La Paz (IdiPAZ), [Mesa,MD] Department of Biochemistry and Molecular Biology II, Institute of Nutrition and Food Technology 'José Mataix', Biomedical Research Center, University of Granada, Granada, Spain. [Mesa,MD] ibs.GRANADA, Instituto de Investigación Biosanitaria, Complejo Hospitalario Universitario de Granada, Granada, Spain. [Loureiro,B] Neonatology Unit, University Hospital Cruces, Biocruces Bizkaia Health Research Institute, Barakaldo, Spain. [Iglesia,I] Growth, Exercise, Nutrition and Development (GENUD) Research Group, Universidad de Zaragoza, Zaragoza, Spain. [Iglesia,I, Rodriguez Martinez,G] Instituto de Investigación Sanitaria Aragón (IIS Aragón), Zaragoza, Spain. [Fernandez Gonzalez,S, García Algar,O, Gómez Roig,D, Perez Gruz,M, Andreu-Fernández,V, Clotet,J, Sailer,S, Iglesias-Platas,I] BCNatal-Barcelona Center for Maternal-Fetal and Neonatal Medicine (Hospital Sant Joan de Deu and Hospital Clínic), Barcelona, Spain. [Fernandez Gonzalez,S, Iglesias-Platas,I] Institut de Recerca Sant Joan de Déu (IR-SJD), Barcelona, Spain. [Llurba Olivé,E] Obstetrics and Gynecology Department, High Risk Unit, Sant Pau University Hospital, Barcelona, Spain. [Llurba Olivé,E] Women and Perinatal Health Research Group, Biomedical Research Institute Sant Pau (IIB-Sant Pau), Sant Pau University Hospital, Barcelona, Spain. [Llurba Olivé,E] School of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain. [García Algar,O, Sailer,S]Neonatology Unit, Hospital Clinic-Maternitat, ICGON, BCNatal, Barcelona, Spain. [Solana,MJ, López-Herce,J] Servicio de Cuidados Intensivos Pediátricos, Hospital General Universitario Gregorio Marañón, Departamento de Salud Pública y Materno infantil, Universidad Complutense de Madrid, Madrid, Spain. [Cabero Perez,MJ] Hospital Universitario Marqués de Valdecilla, Santander, Cantabria, Spain. [Sainz,T, Calvo,C] Servicio de Pediatría, Enfermedades Infecciosas y Tropicales, Hospital La Paz, Madrid, Spain. [Sainz,T, Martinez,L, Aras,R, Calvo,C]Instituto de Investigación Hospital la Paz (IdiPAZ), Madrid, Spain. [Sainz,T, Calvo,C] Red de investigación Traslacional en Infectología Pediátrica (RITIP), Madrid, Spain. [Martinez,L] Servicio de Cirugía Pediátrica, Hospital La Paz, Madrid, Spain. [Escuder-Vieco,D, Pallás-Alonso,C] Donated Milk Bank, Health Research Institute i + 12, University Hospital 12 de Octubre, Universidad Complutense, Madrid, Spain. [Parra-Llorca,A, Vento,M, Gormaz,M] Neonatal Research Group, Health Research Institute La Fe, University and Polytechnic Hospital La Fe, Valencia, Spain. [Sánchez-Campillo,M, Larqué Daza,E] Department of Physiology, Faculty of Biology, University of Murcia, Murcia, Spain. [Rodriguez Martinez,G] Department of Pediatrics, Faculty of Medicine, Hospital Clínico Universitario Lozano Blesa, Zaragoza, Spain. [Iglesias-Platas,I] Neonatology Unit, Hospital Sant Joan de Déu, Institut de Recerca Sant Joan de Déu, BCNatal, Barcelona, Spain. [Saenz de Pipaon,M] Department of Neonatology La Paz University Hospital, Madrid, Spain. [Calvo,C] European Network of Excellence for Pediatric Clinical Research, Bari, Italy. [Cabañas,F] Department of Paediatrics-Neonatology Quironsalud, Madrid University Hospital and Biomedical Research Foundation-IDIPAZ, La Paz University Hospital, Madrid, Spain., This research was funded by the PN I+D+I 2008–2011 (Spain), ISCIII- Sub-Directorate General for Research Assessment and Promotion and the European Regional Development Fund (ERDF), RETICS Maternal and Child Health and Development Network, SAMID Network, Ref. RD16/0022/0015. Anna Parra-Llorca acknowledges Rio Hortega grant CM18/00165 from the Instituto de Investigación en Salud Carlos III (Ministry of Science, Universities and Innovation, Kingdom of Spain), Talía Sainz is funded by The Instituto de Salud Carlos III- Spanish Ministry of Science and Innovation cofounded by FEDER (EU). (Grant nº JR16/00021), and Cristina Calvo is a member of the IdiPAZ Research Institute, Madrid. Spain. Translational Research Network for Pediatric Infectious Diseases (RITIP), Madrid, Spain. TEDDY Network Member (European Network of Excellence for Pediatric Clinical Research, Bari, Italy).
- Subjects
0301 basic medicine ,Infancy ,Allergy ,Embaràs ,microbiome ,Perinatal periods ,Alergia e inmunología ,Review ,Bioinformatics ,Feto ,Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans [Medical Subject Headings] ,sepsis ,0302 clinical medicine ,newborn ,Pregnancy ,Medicine ,030212 general & internal medicine ,Diseases::Bacterial Infections and Mycoses::Infection::Sepsis [Medical Subject Headings] ,Phenomena and Processes::Reproductive and Urinary Physiological Phenomena::Reproductive Physiological Phenomena::Reproductive Physiological Processes::Reproduction::Pregnancy [Medical Subject Headings] ,Nutrition and Dietetics ,Enfermedad crítica ,Microbiota ,fetus ,medicine.anatomical_structure ,Phenomena and Processes::Microbiological Phenomena::Microbiota [Medical Subject Headings] ,allergy, critical illness, fetus, infancy, microbiome, newborn, placenta, pregnancy, sepsis ,Female ,Anatomy::Embryonic Structures::Fetus [Medical Subject Headings] ,lcsh:Nutrition. Foods and food supply ,placenta ,Embarazo ,Medicina ,lcsh:TX341-641 ,03 medical and health sciences ,Fetus ,Recién nacido ,Placenta ,Sepsis ,Humans ,critical illness ,Microbiome ,infancy ,Critically ill ,Pathological ,Organisms::Bacteria [Medical Subject Headings] ,Bacteria ,business.industry ,Infant, Newborn ,Lactante ,medicine.disease ,Early infancy ,allergy ,Newborn ,Infant newborn ,Anatomy::Embryonic Structures::Placenta [Medical Subject Headings] ,Persons::Persons::Age Groups::Infant::Infant, Newborn [Medical Subject Headings] ,030104 developmental biology ,Malalts en estat crític ,Check Tags::Female [Medical Subject Headings] ,business ,Critical illness ,Food Science - Abstract
Pregnancy induces a number of immunological, hormonal, and metabolic changes that are necessary for the mother to adapt her body to this new physiological situation. The microbiome of the mother, the placenta and the fetus influence the fetus growth and undoubtedly plays a major role in the adequate development of the newborn infant. Hence, the microbiome modulates the inflammatory mechanisms related to physiological and pathological processes that are involved in the perinatal progress through di erent mechanisms. The present review summarizes the actual knowledge related to physiological changes in the microbiota occurring in the mother, the fetus, and the child, both during neonatal period and beyond. In addition, we approach some specific pathological situations during the perinatal periods, as well as the influence of the type of delivery and feeding., This research was funded by the PN I+D+I 2008–2011 (Spain), ISCIII- Sub-Directorate General for Research Assessment and Promotion and the European Regional Development Fund (ERDF), RETICS Maternal and Child Health and Development Network, SAMID Network, Ref. RD16/0022/0015. Anna Parra-Llorca acknowledges Rio Hortega grant CM18/00165 from the Instituto de Investigación en Salud Carlos III (Ministry of Science, Universities and Innovation; Kingdom of Spain); Talía Sainz is funded by The Instituto de Salud Carlos III- Spanish Ministry of Science and Innovation cofounded by FEDER (EU). (Grant nº JR16/00021); Cristina Calvo is a member of the IdiPAZ Research Institute, Madrid. Spain. Translational Research Network for Pediatric Infectious Diseases (RITIP), Madrid, Spain. TEDDY Network Member (European Network of Excellence for Pediatric Clinical Research, Bari, Italy)
- Published
- 2020
32. Investigating sources of variability in metabolomic data in the EPIC study: the Principal Component Partial R-square (PC-PR2) method
- Author
-
Bénédicte Elena-Herrmann, Pietro Ferrari, Stefano Monni, Anne Fages, Anna Floegel, Nicolle A. Mode, Elio Riboli, Paolo Chiodini, Hendriek C. Boshuizen, Christina Bamia, Mazda Jenab, Ruth C. Travis, Laure Dossus, Marc Chadeau-Hyam, María-José Sánchez-Pérez, Mattias Johansson, ISA NMR Methods for Metabolism - Methodes RMN en métabolomique (2014-2018), Institut des Sciences Analytiques (ISA), Institut de Chimie du CNRS (INC)-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Centre National de la Recherche Scientifique (CNRS)-Institut de Chimie du CNRS (INC)-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Centre National de la Recherche Scientifique (CNRS), International Agency for Cancer Research (IACR), Division of Cancer Epidemiology, German Cancer Research Center - Deutsches Krebsforschungszentrum [Heidelberg] (DKFZ), Centre de recherche en épidémiologie et santé des populations (CESP), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Université Paris-Sud - Paris 11 (UP11)-Hôpital Paul Brousse-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Versailles Saint-Quentin-en-Yvelines (UVSQ), Department of Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Department of Community Medicine Systems Epidemiology, University of Tromsø (UiT), Department of Biobank Research, Umeå University, Cancer Epidemiology Unit, University of Oxford [Oxford], WHO Collaborating Center for Food and Nutrition Policies, Department of Hygiene, Epidemiology and Medical Statistics, University of Athens Medical School, Granada Cancer Registry, University of Naples Federico II, National Institute for Public Health and the Environment [Bilthoven] (RIVM), Department of Epidemiology and Biostatistics, Imperial College London, Fages, A, Ferrari, P, Monni, S, Dossus, L, Floegel, A, Mode, N, Johansson, M, Travis, Rc, Bamia, C, Sanchez Perez, Mj, Chiodini, Paolo, Boshuizen, Hc, Chadeau Hyam, M, Riboli, E, Jenab, M, and Elena Herrmann, B.
- Subjects
Systematic variation ,Disease status ,Coefficient of determination ,European prospective investigation on cancer and nutrition ,Nutrition and Disease ,Epidemiology ,Endocrinology, Diabetes and Metabolism ,Clinical Biochemistry ,Principal component analysis ,Computational biology ,Biology ,Bioinformatics ,Biochemistry ,Wiskundige en Statistische Methoden - Biometris ,Nuclear magnetic resonance ,Metabolomics ,[CHIM.ANAL]Chemical Sciences/Analytical chemistry ,Voeding en Ziekte ,Mathematical and Statistical Methods - Biometris ,2. Zero hunger ,PE&RC ,3. Good health ,European Prospective Investigation into Cancer and Nutrition ,Fasting Status ,Epic study ,Body mass index - Abstract
The key goal of metabolomic studies is to identify relevant individual biomarkers or composite metabolic patterns associated with particular disease status or patho-physiological conditions. There are currently very few approaches to evaluate the variability of metabolomic data in terms of characteristics of individuals or aspects pertaining to technical processing. To address this issue, a method was developed to identify and quantify the contribution of relevant sources of variation in metabolomic data prior to investigation of etiological hypotheses. The Principal Component Partial R-square (PC-PR2) method combines features of principal component and of multivariable linear regression analyses. Within the European Prospective Investigation into Cancer and nutrition (EPIC), metabolic profiles were determined by 1H NMR analysis on 807 serum samples originating from a nested liver cancer case-control study. PC-PR2 was used to quantify the variability of metabolomic profiles in terms of study subjects age, sex, body mass index, country of origin, smoking status, diabetes and fasting status, as well as factors related to sample processing. PC-PR2 enables the evaluation of important sources of variations in metabolomic studies within large-scale epidemiological investigations. © 2014 Springer Science+Business Media New York.
- Published
- 2014
- Full Text
- View/download PDF
33. Methylome Analysis and Epigenetic Changes Associated with Menarcheal Age
- Author
-
Sabina Sieri, Karin van Veldhoven, Marina Kvaskoff, Cyrille Cuenin, Heiner Boeing, Angela Risch, Isabelle Romieu, Marc J. Gunter, Jia Chen, Nicholas J. Wareham, Salvatore Panico, Gianluca Campanella, María José Sánchez Pérez, Ruth C. Travis, Zdenko Herceg, Pagona Lagiou, José María Huerta Castaño, Silvia Polidoro, Kevin Brennan, Giovanna Masala, Rudolf Kaaks, J. Ramón Quirós, Eva Ardanaz, Petra H.M. Peeters, Timothy J. Key, Laure Dossus, Dagmar Drogan, Françoise Clavel-Chapelon, Pilar Amiano, James M. Flanagan, Kyriacos Kyriacou, Dimitrios Trichopoulos, Rosario Tumino, Kay-Tee Khaw, Valentina Gallo, Charlotte Onland-Moret, Paolo Vineis, Christiana A. Demetriou, Elio Riboli, Demetriou, Ca, Chen, J, Polidoro, S, van Veldhoven, K, Cuenin, C, Campanella, G, Brennan, K, Clavel Chapelon, F, Dossus, L, Kvaskoff, M, Drogan, D, Boeing, H, Kaaks, R, Risch, A, Trichopoulos, D, Lagiou, P, Masala, G, Sieri, S, Tumino, R, Panico, Salvatore, Quir?s, Jr, S?nchez Perez, Mj, Amiano, P, Huerta Casta?o, Jm, Ardanaz, E, Onland Moret, C, Peeters, P, Khaw, Kt, Wareham, N, Key, Tj, Travis, Rc, Romieu, I, Gallo, V, Gunter, M, Herceg, Z, Kyriacou, K, Riboli, E, Flanagan, Jm, and Vineis, P.
- Subjects
Adult ,BLOOD-CELLS ,HYPOMETHYLATION ,IMPACT ,Population ,Luma ,Physiology ,lcsh:Medicine ,Locus (genetics) ,Biology ,Epigenesis, Genetic ,03 medical and health sciences ,0302 clinical medicine ,Humans ,BREAST-CANCER ,Epigenetics ,Prospective Studies ,education ,lcsh:Science ,POPULATION ,030304 developmental biology ,Aged ,Genetics ,Menarche ,RISK ,0303 health sciences ,education.field_of_study ,Multidisciplinary ,Science & Technology ,MULTIDISCIPLINARY SCIENCES ,lcsh:R ,Methylation ,DNA Methylation ,Middle Aged ,LEUKOCYTE DNA ,CpG site ,030220 oncology & carcinogenesis ,DNA methylation ,COLORECTAL ADENOMA ,PATTERNS ,Science & Technology - Other Topics ,lcsh:Q ,CpG Islands ,Female ,GENOMIC DNA METHYLATION ,Research Article - Abstract
Reproductive factors have been linked to both breast cancer and DNA methylation, suggesting methylation as an important mechanism by which reproductive factors impact on disease risk. However, few studies have investigated the link between reproductive factors and DNA methylation in humans. Genome-wide methylation in peripheral blood lymphocytes of 376 healthy women from the prospective EPIC study was investigated using LUminometric Methylation Assay (LUMA). Also, methylation of 458877 CpG sites was additionally investigated in an independent group of 332 participants of the EPIC-Italy sub-cohort, using the Infinium HumanMethylation 450 BeadChip. Multivariate logistic regression and linear models were used to investigate the association between reproductive risk factors and genome wide and CpG-specific DNA methylation, respectively. Menarcheal age was inversely associated with global DNA methylation as measured with LUMA. For each yearly increase in age at menarche, the risk of having genome wide methylation below median level was increased by 32% (OR:1.32, 95%CI:1.14-1.53). When age at menarche was treated as a categorical variable, there was an inverse dose-response relationship with LUMA methylation levels (OR(12-14 vs. ≤11 yrs):1.78, 95%CI:1.01-3.17 and OR(≥15 vs. ≤11 yrs):4.59, 95%CI:2.04-10.33; P for trend
- Published
- 2013
34. Ethanol Intake and Risk of Lung Cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC)
- Author
-
Pietro Ferrari, Paolo Vineis, John C. Whittaker, Anne Tjønneland, Rosario Tumino, Torgny Rasmuson, Frederike L. Büchner, Hendriek C. Boshuizen, Timothy J. Key, María Dolores Chirlaque, Marie-Christine Boutron-Ruault, Françoise Clavel-Chapelon, Domenico Palli, Salvatore Panico, Manuela M. Bergmann, Eva Ardanaz, Majken K. Jensen, H. Bas Bueno-de-Mesquita, Jakob Linseisen, Inger T. Gram, Sabine Rohrmann, Göran Berglund, Petra H.M. Peeters, Elio Riboli, Eiliv Lund, Teresa Norat, Kim Overvad, Stavroula Soukara, María José Sánchez Pérez, Sabina Sieri, Lars Weinehall, Anja Olsen, Antonio Agudo, Naomi E. Allen, Mazda Jenab, Georgia Kyriazi, Sheila Bingham, Antonia Trichopoulou, Lars Janzon, José Ramón Quirós, Paolo Boffetta, Miren Dorronsoro, Kay-Tee Khaw, Heiner Boeing, Rohrmann, S, Linseisen, J, Boshuizen, Hc, Whittaker, J, Agudo, A, Vineis, P, Boffetta, P, Jensen, Mk, Olsen, A, Overvad, K, Tjonneland, A, BOUTRON RUAULT, Mc, CLAVEL CHAPELON, F, Bergmann, Mm, Boeing, H, Allen, N, Key, T, Bingham, S, Khaw, Kt, Kyriazi, G, Soukara, S, Trichopoulou, A, Panico, Salvatore, Palli, D, Sieri, S, Tumino, R, Peeters, Ph, BUENO DE MESQUITA, Hb, Buchner, Fl, Gram, It, Lund, E, Ardanaz, E, Chirlaque, Md, Dorronsoro, M, Perez, Mj, Quiros, Jr, Berglund, G, Janzon, L, Rasmuson, T, Weinehall, L, Ferrari, P, Jenab, M, Norat, T, Riboli, E., Rohrmann, S., Linseisen, J., Boshuizen, H.C., Whittaker, J., Agudo, A., Vineis, P., Boffetta, P., Jensen, M.K., Olsen, A., Overvad, K., Tjønneland, A., Boutron-Ruault, M.-C., Clavel-Chapelon, F., Bergmann, M.M., Boeing, H., Allen, N., Key, T., Bingham, S., Khaw, K.-T., Kyriazi, G., Soukara, S., Trichopoulou, A., Panico, S., Palli, D., Sieri, S., Tumino, R., Peeters, P.H.M., Bueno-De-Mesquita, H.B., Büchner, F.L., Gram, I.T., Lund, E., Ardanaz, E., Chirlaque, M.-D., Dorronsoro, M., Pérez, M.-J.S., Quirós, J.R., Berglund, G., Janzon, L., Rasmuson, T., Weinehall, L., Ferrari, P., Jenab, M., and Norat, T.
- Subjects
Adult ,Male ,medicine.medical_specialty ,Epidemiology ,lung neoplasms ,Lower risk ,Risk Assessment ,cohort studies ,Risk Factors ,Interventional oncology [UMCN 1.5] ,Surveys and Questionnaires ,Internal medicine ,Determinants in Health and Disease [EBP 1] ,Humans ,Medicine ,Prospective Studies ,ddc:610 ,Risk factor ,Lung cancer ,alcohol drinking ,ethanol ,Proportional Hazards Models ,Ethanol intake and risk of lung cancer ,business.industry ,Incidence ,Hazard ratio ,Middle Aged ,Anthropometry ,medicine.disease ,Confidence interval ,European Prospective Investigation into Cancer and Nutrition ,Surgery ,Europe ,Female ,business ,Follow-Up Studies ,Cohort study - Abstract
Contains fulltext : 49956.pdf (Publisher’s version ) (Closed access) Within the European Prospective Investigation into Cancer and Nutrition (EPIC), the authors examined the association of ethanol intake at recruitment (1,119 cases) and mean lifelong ethanol intake (887 cases) with lung cancer. Information on baseline and past alcohol consumption, lifetime tobacco smoking, diet, and the anthropometric characteristics of 478,590 participants was collected between 1992 and 2000. Cox proportional hazards regression was used to calculate multivariate-adjusted hazard ratios and 95% confidence intervals. Overall, neither ethanol intake at recruitment nor mean lifelong ethanol intake was significantly associated with lung cancer. However, moderate intake (5-14.9 g/day) at recruitment (hazard ratio (HR) = 0.76, 95% confidence interval (CI): 0.63, 0.90) and moderate mean lifelong intake (HR = 0.80, 95% CI: 0.66, 0.97) were associated with a lower lung cancer risk in comparison with low consumption (0.1-4.9 g/day). Compared with low intake, a high (> or =60 g/day) mean lifelong ethanol intake tended to be related to a higher risk of lung cancer (HR = 1.29, 95% CI: 0.93, 1.74), but high intake at recruitment was not. Although there was no overall association between ethanol intake and risk of lung cancer, the authors cannot rule out a lower risk for moderate consumption and a possibly increased risk for high lifelong consumption.
- Published
- 2006
35. Lipid-targeting antiviral strategies: Current state and future perspectives.
- Author
-
Blázquez AB, Mingo-Casas P, Quesada E, Priego EM, Pérez-Perez MJ, and Martín-Acebes MA
- Abstract
There is an urgent need for antiviral compounds effective against currently known and future viral threats. The development of host-targeting antivirals (HTAs) appears as an alternative strategy to fight viral infections minimizing the potential of resistant mutant development and potentially leading to the identification of broad-spectrum antiviral agents. Among the host factors explored for HTA strategy, lipids constitute an attractive target as many viruses, even genetically diverse, hijack specific lipids during their lifecycle. Multiple repurposing efforts have been performed to analyze the antiviral properties of lipid-targeting compounds. These studies include the analysis of the effects of cholesterol lowering drugs such as statins, cholesterol transport inhibitors, sphingolipid modulators, de novo lipogenesis inhibitors blocking fatty acid synthesis, compounds targeting glycerophospholipids or drugs interfering with lipid droplet metabolism. This review is focused on the current status of lipid-based or lipid-targeting antiviral strategies and their potential for the development of antiviral therapies, with special emphasis on those studies that have reached advanced stages of development such as efficacy studies in animal models or clinical trials. Whereas there is still a long way to go, multiple proof-of-concept studies and clinical evidence reinforce the therapeutic potential of these strategies warranting their further development into effective antiviral therapies., Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2025. Published by Elsevier B.V.)
- Published
- 2025
- Full Text
- View/download PDF
36. Sex- and site-specific associations of circulating lipocalin 2 and incident colorectal cancer: Results from the EPIC cohort.
- Author
-
Reichmann R, Nimptsch K, Pischon T, Gunter MJ, Jenab M, Eriksen AK, Tjonneland A, Janke J, Katzke V, Kaaks R, Schulze MB, Eichelmann F, Masala G, Sieri S, Pasanisi F, Tumino R, Giraudo MT, Rothwell J, Severi G, Jakszyn P, Sanchez-Perez MJ, Amiano P, Colorado-Yohar SM, Guevara M, van Guelpen B, Aglago EK, Heath AK, Smith-Byrne K, Weiderpass E, and Aleksandrova K
- Subjects
- Humans, Male, Female, Middle Aged, Case-Control Studies, Aged, Prospective Studies, Incidence, Biomarkers, Tumor blood, Sex Factors, Adult, Risk Factors, Europe epidemiology, Lipocalins blood, Lipocalin-2 blood, Colorectal Neoplasms blood, Colorectal Neoplasms epidemiology, Colorectal Neoplasms diagnosis
- Abstract
Experimental research has uncovered lipocalin 2 (LCN2) as a novel biomarker implicated in the modulation of intestinal inflammation, metabolic homeostasis, and colon carcinogenesis. However, evidence from human research has been scant. We, therefore, explored the association of pre-diagnostic circulating LCN2 concentrations with incident colorectal cancer (CRC) in a nested case-control study within the in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. LCN2 was measured in 1267 incident CRC cases matched to 1267 controls using incidence density sampling. Conditional logistic regression was used to estimate incidence rate ratios (IRRs) and 95% confidence intervals (95% CIs) according to tumor subsite and sex. Weighted Cox proportional hazard regression was used to explore associations by adiposity status. In multivariable-adjusted analyses, the IRR [95% CI] per doubling in LCN2 concentration was 1.16 [0.98-1.37] for CRC overall, 1.26 [1.00-1.59] for colon cancer, and 1.08 [0.85-1.38] for rectal cancer. The association for colon cancer was more pronounced in women (IRR [95% CI], 1.66 [1.20-2.30]) and for proximal colon cancer (IRR [95% CI], 1.96 [1.15-3.34]), whereas no association was seen in men and distal colon cancer. The association for colon cancer was positive in individuals with high waist circumference (hazard ratio [95% CI], 1.69 [1.52-1.88]) and inverse in individuals with low waist circumference (hazard ratio [95% CI], 0.86 [0.76-0.98], P interaction<0.01). Overall, these data suggest that pre-diagnostic LCN2 concentrations were positively associated with colon cancer, particularly occurring in the proximal colon, in women and among individuals with abdominal adiposity., (© 2024 The Author(s). International Journal of Cancer published by John Wiley & Sons Ltd on behalf of UICC.)
- Published
- 2025
- Full Text
- View/download PDF
37. The impact of the COVID-19 pandemic on childhood vaccination rates and the role of sociodemographic factors: A cohort study.
- Author
-
Gómez-Acebo I, Barquín-Ruiz A, Llorente S, Alonso-Molero J, Llorca J, Cabero-Perez MJ, and Dierssen-Sotos T
- Subjects
- Humans, Female, Infant, Male, Cohort Studies, SARS-CoV-2 immunology, Pandemics prevention & control, Adult, Mothers statistics & numerical data, Vaccination Coverage statistics & numerical data, Infant, Newborn, COVID-19 prevention & control, COVID-19 epidemiology, Vaccination statistics & numerical data, Socioeconomic Factors, Sociodemographic Factors
- Abstract
Objective: This study examines the impact of the COVID-19 pandemic on both routine and non-routine vaccinations in infants during their initial 18 months of life, concurrently exploring the complex influence of sociodemographic factors., Methods: A cohort study was conducted, involving 2007 children in two distinct periods: pre-pandemic (January-June 2018) and pandemic (March 2020-May 2021). Participants were classified into two cohorts: 962 children in the 2018 group and 1045 children in the 2020-21 group. Utilizing unconditional logistic regression, the association between vaccination (complete or non-routine) and socioeconomic factors was examined, with adjustments for potential confounding variables such as age, breastfeeding, gestational age, and twins., Results: The study's analysis reveals that in the post-pandemic period, mothers were three times more likely to opt for non-routine vaccines (95% CI 2.25-4.23). However, no significant alterations were observed in routine vaccination rates. Protective factors for complete vaccination included having an employed mother, higher education, and a medium-to-high income. Conversely, a higher income was associated with a reduced likelihood of complete vaccination (OR 0.34, 95% CI 0.20-0.59)., Conclusion: Contrary to initial expectations, this study concludes that the COVID-19 pandemic did not have a substantial impact on childhood complete vaccination rates. Nevertheless, a noticeable increase in the choice of non-routine vaccination was observed. Sociodemographic factors, such as maternal education, income, and employment status, emerged as key influencers, particularly in the context of deciding on non-routine vaccinations., Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2024. Published by Elsevier Ltd.)
- Published
- 2024
- Full Text
- View/download PDF
38. Adjunctive azithromycin for scheduled cesarean delivery in patients with obesity: a secondary analysis of a randomized controlled trial.
- Author
-
Perez MJ, Tuuli MG, Tita ATN, Carter EB, Macones GA, and Harper LM
- Subjects
- Humans, Female, Pregnancy, Adult, Antibiotic Prophylaxis methods, Azithromycin administration & dosage, Cesarean Section methods, Anti-Bacterial Agents administration & dosage, Obesity
- Published
- 2024
- Full Text
- View/download PDF
39. Each one, teach one: Critical history as counterstories, antiracist affordances, and cues for belonging.
- Author
-
Salter PS, Perez MJ, Battle JS, and Crist JD
- Subjects
- Humans, Systemic Racism, Racism, Cues, Psychology education, Psychology history, Curriculum
- Abstract
Recently, there have been several calls for psychologists to dismantle systemic racism within the field (e.g., Buchanan et al., 2021; Dupree & Boykin, 2021; Wilcox et al., 2022). In this article, we discuss why incorporating critical histories into psychology curricula can be beneficial to this effort. We focus on three potential pathways: critical histories provide counterstories that challenge racist narratives, critical histories promote contexts that encourage antiracism practices (antiracist affordances), and critical histories can signal identity safety and belonging. To adequately integrate critical histories into psychology curricula, we make three recommendations. First, create and support a departmental curriculum that engages critical histories in the field of psychology at the undergraduate and graduate level (we offer some example topics and readings). Second, based on our own training experiences, we recommend that psychology graduate programs facilitate opportunities to take interdisciplinary courses that cover the history of race and racism in domestic and/or global contexts. Finally, we recommend funding research and supporting student projects that produce critical histories in psychology to expand the knowledge base of our field. (PsycInfo Database Record (c) 2024 APA, all rights reserved).
- Published
- 2024
- Full Text
- View/download PDF
40. Association Between Assisted Reproductive Technology and Cerebral Palsy: A Meta-Analysis.
- Author
-
Cavero-Ibiricu A, Canelas-Fernández J, Gómez-Acebo I, Alonso-Molero J, Martínez-Jiménez D, Llorca J, Cabero-Perez MJ, and Dierssen-Sotos T
- Subjects
- Female, Humans, Infant, Newborn, Pregnancy, Pregnancy Outcome, Pregnancy, Multiple, Reproductive Techniques, Assisted adverse effects, Cerebral Palsy epidemiology, Cerebral Palsy etiology, Premature Birth epidemiology
- Abstract
Background: Since 1978 many children are born thanks to assisted reproductive technology (ART). However, the long-term effects of these therapies are still not fully known. Our objective is to evaluate the risk of cerebral palsy (CP) after ART compared with that in those spontaneously conceived (SC) and to examine this risk in single, multiple, and preterm births and the evolution of the risk over the years., Methods: PubMed, Embase, and Web of Science databases were searched until December 2022. Studies were included if they studied CP cases in children born through ART. 16 studies were finally selected. Quality of studies was assessed using Newcastle Ottawa Scale. Pooled OR was estimated by weighting individual OR/RR by the inverse of their variance. A random-effect model was applied. To assess the causes of heterogeneity, we performed meta-regression analyses., Results: A significantly high risk of CP was found (OR = 1.27; 95% CI 1.12 to 1.43) in children born through ART compared with those SC. This risk increased in singletons (OR = 1.48; 95% CI 1.23 to 1.79) but disappeared in multiple (OR = 1.05; 95% CI 0.93 to 1.18) and preterm births (OR = 1.09; 95% CI 0.87 to 1.37). We found a higher risk of CP in children born before the year 2000 (OR = 3.40; 95% CI 2.49 to 4.63)., Conclusions: ARTs slightly increase the risk of CP once the effect of multiple gestation is controlled. Further studies are needed to clarify whether the techniques themselves, fertility problems, or associated maternal comorbidities are responsible for this risk., Competing Interests: Declaration of competing interest The authors have no conflicts of interest to disclose., (Copyright © 2023 The Author(s). Published by Elsevier Inc. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
41. Irreversible electroporation: Beyond the limits of tumor ablation.
- Author
-
Alonso-González R, Abadal Villayandre JM, Gálvez Gonzalez E, Álvarez Perez MJ, Méndez Alonso S, and de Gregorio Ariza MA
- Subjects
- Male, Humans, Electroporation methods, Pancreas, Liver Neoplasms, Ablation Techniques methods, Prostatic Neoplasms
- Abstract
Irreversible Electroporation (IRE) is a non-thermal tumor ablation technique. High-voltage electrical pulses are applied between pairs of electrodes inserted around and/or inside a tumor. The generated electric current induces the creation of nanopores in the cell membrane, triggering apoptosis. As a result, IRE can be safely used in areas near delicate vascular structures where other thermal ablation methods are contraindicated. Currently, IRE has demonstrated to be a successful ablation technique for pancreatic, renal, and liver tumors and is widely used as a focal therapeutic option for prostate cancer. The need for specific anesthetic management and accurate parallel placement of multiple electrodes entails a high level of complexity and great expertise from the interventional team is required. Nevertheless, IRE is a very promising technique with a remarkable systemic immunological capability and may impact on distant metastases (abscopal effect)., (Copyright © 2023 SERAM. Published by Elsevier España, S.L.U. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
42. Macro1 domain residue F156: A hallmark of SARS-CoV-2 de-MARylation specificity.
- Author
-
Ortega Granda O, Alvarez K, Mate-Perez MJ, Canard B, Ferron F, and Rabah N
- Abstract
SARS-CoV-2 is a large, enveloped and positive sense single stranded RNA virus. Its genome codes for 16 non-structural proteins. The largest protein of this complex is nsp3, that contains a well conserved Macro1 domain. Viral Macro domains were shown to bind to mono-ADP-ribose (MAR) and poly-ADP-ribose (PAR) in their free form or conjugated to protein substrates. They carry ADP-ribose hydrolase activities implicated in the regulation of innate immunity. SARS-CoV-2 and SARS-CoV show widely different induction and handling of the host interferon response. Herein, we have conducted a mutational study on the key amino-acid residue F156 in SARS-CoV-2, pinpointed by bioinformatic and structural studies, and its cognate residue N157 in SARS-CoV. Our data suggest that the exchange of these residues slightly modifies ADP-ribose binding, but drastically impacts de-MARylation activity. Alanine substitutions at this position hampers PAR binding, abolishes MAR hydrolysis of SARS-CoV-2, and reduces by 70% this activity in the case of SARS-CoV., Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2023 Elsevier Inc. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
43. The use of ICSI in ART: evidence for practice.
- Author
-
Bolton VN, Perez MJ, Hughes G, Moodley T, Dean M, Fernandez-Ponce A, Southall-Brown G, and Kasraie J
- Abstract
This article reviews the evidence regarding the safety and efficacy of intra-cytoplasmic sperm injection (ICSI). It provides evidence-based clinical and laboratory guidelines and recommendations for use of ICSI within an assisted reproductive technology (ART) service. The guidelines address the evidence for the use of ICSI rather than conventional IVF (cIVF); the use of ART techniques supplementary to ICSI; and risks associated with ICSI. This article is not intended to be the only approved standard of practice or to dictate an exclusive course of treatment. Other plans of management may be appropriate, taking into account the needs and medical history of the patient, available resources, and institutional or clinical practice limitations.
- Published
- 2023
- Full Text
- View/download PDF
44. New insights into the autophagy-NAD axis in brain disease.
- Author
-
Perez MJ and Deleidi M
- Subjects
- Humans, Neurons, Autophagy, NAD, Brain Diseases
- Abstract
Sun et al. demonstrate that defects in autophagy cause nicotinamide adenine dinucleotide (NAD) depletion and neurotoxicity.
1 Restoring NAD levels rescues cytotoxicity in autophagy-deficient neurons, providing a potential therapy for neurodegenerative and lysosomal storage diseases associated with autophagy defects., Competing Interests: Declaration of interests The authors declare no competing interests., (Copyright © 2023 The Authors. Published by Elsevier Inc. All rights reserved.)- Published
- 2023
- Full Text
- View/download PDF
45. Glucocerebrosidase is imported into mitochondria and preserves complex I integrity and energy metabolism.
- Author
-
Baden P, Perez MJ, Raji H, Bertoli F, Kalb S, Illescas M, Spanos F, Giuliano C, Calogero AM, Oldrati M, Hebestreit H, Cappelletti G, Brockmann K, Gasser T, Schapira AHV, Ugalde C, and Deleidi M
- Subjects
- Humans, Proteomics, Mitochondria genetics, Mitochondria metabolism, Energy Metabolism genetics, Mutation, Lysosomes metabolism, alpha-Synuclein metabolism, Mitochondrial Proteins metabolism, ATP-Dependent Proteases metabolism, Glucosylceramidase genetics, Glucosylceramidase metabolism, Parkinson Disease metabolism
- Abstract
Mutations in GBA1, the gene encoding the lysosomal enzyme β-glucocerebrosidase (GCase), which cause Gaucher's disease, are the most frequent genetic risk factor for Parkinson's disease (PD). Here, we employ global proteomic and single-cell genomic approaches in stable cell lines as well as induced pluripotent stem cell (iPSC)-derived neurons and midbrain organoids to dissect the mechanisms underlying GCase-related neurodegeneration. We demonstrate that GCase can be imported from the cytosol into the mitochondria via recognition of internal mitochondrial targeting sequence-like signals. In mitochondria, GCase promotes the maintenance of mitochondrial complex I (CI) integrity and function. Furthermore, GCase interacts with the mitochondrial quality control proteins HSP60 and LONP1. Disease-associated mutations impair CI stability and function and enhance the interaction with the mitochondrial quality control machinery. These findings reveal a mitochondrial role of GCase and suggest that defective CI activity and energy metabolism may drive the pathogenesis of GCase-linked neurodegeneration., (© 2023. The Author(s).)
- Published
- 2023
- Full Text
- View/download PDF
46. Time of leaving work pregnancy results during COVID-19 pandemic. The MOACC-19 cohort from Spain.
- Author
-
Llorca J, Dierssen-Sotos T, Carrasco-Marín E, Guerra-Díez JL, Lechosa-Muñiz C, Paz-Zulueta M, Gómez-Acebo I, and Cabero-Perez MJ
- Subjects
- Humans, Pregnancy, Female, Cohort Studies, Pandemics, Spain epidemiology, Parturition, COVID-19 epidemiology
- Abstract
Background: COVID-19 pandemic has changed the way pregnancies have been controlled as well as working conditions. In countries with paid leave of work, leaving earlier has been a relevant measure for controlling the pandemic. No study has been published on factors associated with earlier leaving work in pregnancy and the consequences it could have on pregnancy outcomes., Objective: We aimed to identify woman and pregnancy characteristics associated with leaving work earlier and its consequences on pregnancy results., Method: A cohort study was carried out in Cantabria, Northern Spain, including 760 women who were pregnant in 2020 and were working at the beginning of their pregnancy. Data on pregnancy characteristics and results were obtained from medical records and gestational age at leaving work was self-reported. In a logistic regression analysis, leaving work before 26th week of pregnancy was the main effect variable., Results: Several factors were associated with lower probability of leaving work before 26th week, including university studies (OR = 0.49, 95% CI: 0.36, 0.68), having presential work (OR = 0.57, 95% CI: 0.40, 0.81), women born in non-European countries (OR = 0.55, 95% CI: 0.30, 1.01) and non-smokers (OR for smokers = 1.79, 95% CI: 1.12, 2.87). Neither type of delivery, gestational age at delivery nor other pregnancy results were associated with the gestational age of leaving work., Conclusion: Several pregnancy and women characteristics were associated with leaving work earlier in the COVID-19 pandemic, although it was not associated with any pregnancy outcome., (© 2023. The Author(s).)
- Published
- 2023
- Full Text
- View/download PDF
47. Impact of HCV Treatment on Recurrence of Hepatocarcinoma After Liver Transplantation.
- Author
-
Burgos MM, Grande RG, Ortega SL, Leiva IS, Lombardo JC, Santoyo JS, and Perez MJ
- Subjects
- Humans, Hepacivirus, Neoplasm Recurrence, Local, Liver Cirrhosis complications, Recurrence, Liver Transplantation adverse effects, Hepatitis C etiology, Carcinoma, Hepatocellular complications, Liver Neoplasms complications
- Abstract
The treatment of hepatitis C virus (HCV) has been a revolution in hepatology. Since the beginning of transplantation, liver cirrhosis and hepatocarcinoma on HCV cirrhosis has been the main etiology of liver transplantation. We set out to analyze the impact that C virus treatment has had on liver transplantation. To do so, we divided our cohort into 2 periods, one before virus treatment (from 2000-2014) and one after the onset of treatment (2014-2020). Taking into account this differentiation, we analyzed the percentage of patients transplanted for hepatocarcinoma over cirrhotic liver by HCV in both groups. Among the patients transplanted for HCV, we analyzed whether there were differences in hepatocarcinoma recurrences according to their serologic status at the time of transplantation., (Published by Elsevier Inc.)
- Published
- 2023
- Full Text
- View/download PDF
48. COVID Vaccine Information Sources Utilized by Female Healthcare Workers.
- Author
-
Paul R, Raghuraman N, Carter EB, Odibo AO, Kelly JC, Foeller ME, and Perez MJ
- Abstract
Background: Clinical trials of the messenger RNA COVID-19 vaccines excluded individuals with active reproductive needs (attempting to conceive, currently pregnant, and/or lactating). Women comprise three-quarters of healthcare workers in the United States-an occupational field among the first to receive the vaccine. Professional medical and government organizations have encouraged shared decision-making and access to vaccination among those with active reproductive needs., Objective: This study aimed to characterize the information sources used by pregnancy-capable healthcare workers for information about the COVID-19 vaccines and to compare the self-reported "most important" source by the respondents' active reproductive needs, if any., Study Design: This was a web-based national survey of female, US-based healthcare workers in January 2021. Recruitment was done using social media and subsequent sharing via word of mouth. We classified the respondents into 6 groups on the basis of self-reported reproductive needs as follows: (1) preventing pregnancy, (2) attempting pregnancy, (3) currently pregnant, (4) lactating, (5) attempting pregnancy and lactating, and (6) currently pregnant and lactating. We provided respondents with a list of information sources (friends, family, obstetrician-gynecologists, pediatrician, news, social media, government organizations, their employer, and "other") and asked respondents which source(s) they used when looking for information about the vaccine and their most important source. We used descriptive statistics to characterize the information sources and compared the endorsement of government organizations and obstetrician-gynecologists, which were the most important information source between reproductive groups, using the chi-square test. The effect size was calculated using Cramér V., Results: Our survey had 11,405 unique respondents: 5846 (51.3%) were preventing pregnancy, 955 (8.4%) were attempting pregnancy, 2196 (19.3%) were currently pregnant, 2250 (19.7%) were lactating, 67 (0.6%) were attempting pregnancy and lactating, and 91 (0.8%) were currently pregnant and lactating. The most endorsed information sources were government organizations (88.7%), employers (48.5%), obstetrician-gynecologists (44.9%), and social media (39.6%). Considering the most important information source, the distribution of respondents endorsing government organizations was different between reproductive groups (P<.001); it was most common among respondents preventing pregnancy (62.6%) and least common among those currently pregnant (31.5%). We observed an inverse pattern among the respondents endorsing an obstetrician-gynecologist as the most important source; the source was most common among currently pregnant respondents (51.4%) and least common among those preventing pregnancy (5.8%), P<.001. The differences in the endorsement of social media as an information source between groups were significant but had a small effect size., Conclusion: Healthcare workers use government and professional medical organizations for information. Respondents attempting pregnancy and those pregnant and/or lactating are more likely to use social media and an obstetrician-gynecologist as information sources for vaccine decision-making. These data can inform public health messaging and counseling for clinicians., (Copyright © 2022 Elsevier Inc. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
49. Contribution of fatty acid oxidation to the pathogenesis of pulmonary hypertension.
- Author
-
Lee MH, Sanders L, Kumar R, Hernandez-Saavedra D, Yun X, Ford JA, Perez MJ, Mickael C, Gandjeva A, Koyanagi DE, Harral JW, Irwin DC, Kassa B, Eckel RH, Shimoda LA, Graham BB, and Tuder RM
- Subjects
- Animals, Disease Models, Animal, Fatty Acids metabolism, Female, Humans, Hypoxia metabolism, Mice, Pulmonary Artery metabolism, Rats, Vascular Remodeling, Hypertension, Pulmonary pathology, Pulmonary Arterial Hypertension, Scleroderma, Systemic pathology
- Abstract
Dysregulated metabolism characterizes both animal and human forms of pulmonary hypertension (PH). Enzymes involved in fatty acid metabolism have previously not been assessed in human pulmonary arteries affected by pulmonary arterial hypertension (PAH), and how inhibition of fatty acid oxidation (FAO) may attenuate PH remains unclear. Fatty acid metabolism gene transcription was quantified in laser-dissected pulmonary arteries from 10 explanted lungs with advanced PAH (5 idiopathic, 5 associated with systemic sclerosis), and 5 donors without lung diseases. Effects of oxfenicine, a FAO inhibitor, on female Sugen 5416-chronic hypoxia (SuHx) rats were studied in vivo using right heart catheterization, and ex vivo using perfused lungs and pulmonary artery ring segments. The impact of pharmacologic (oxfenicine) and genetic (carnitine palmitoyltransferase 1a heterozygosity) FAO suppression was additionally probed in mouse models of Schistosoma and hypoxia-induced PH. Potential mechanisms underlying FAO-induced PH pathogenesis were examined by quantifying ATP and mitochondrial mass in oxfenicine-treated SuHx pulmonary arterial cells, and by assessing pulmonary arterial macrophage infiltration with immunohistochemistry. We found upregulated pulmonary arterial transcription of 26 and 13 FAO genes in idiopathic and systemic sclerosis-associated PAH, respectively. In addition to promoting de-remodeling of pulmonary arteries in SuHx rats, oxfenicine attenuated endothelin-1-induced vasoconstriction. FAO inhibition also conferred modest benefit in the two mouse models of PH. Oxfenicine increased mitochondrial mass in cultured rat pulmonary arterial cells, and decreased the density of perivascular macrophage infiltration in pulmonary arteries of treated SuHx rats. In summary, FAO inhibition attenuated experimental PH, and may be beneficial in human PAH.
- Published
- 2022
- Full Text
- View/download PDF
50. Innovative Social Media Summit: Providing a Path for Physicians on Social Media.
- Author
-
Perez MJ, Omurtag K, Aagaard E, Klingensmith M, and Bhayani RK
- Subjects
- Humans, Mentors, Reproducibility of Results, Mentoring, Physicians, Social Media
- Abstract
Problem: Physicians' voices are valued in society and should be present in mainstream social media where they can provide valuable public health messaging and patient education as well as increase opportunities for medical education, mentoring, and collaboration. However, lack of formal education on effective use of social media prevents many physicians from using it., Approach: The authors developed a physician-led social media training program to address the need for formal instruction on social media use. The program was presented to medical students, trainees, and faculty at an academic medical institution in August and September 2020. The virtual format included 5 hour-long sessions with presentations by peer experts in social media. Peer physicians with experience using social media presented on a range of topics, including introductions to platforms, how to reach and grow audiences, and use of social media to advance patient education, medical education, and advocacy., Outcomes: There were 425 cumulative registrations for the 5 sessions of the Social Media Summit. The number of registrants increased for each session, suggesting that interest increased over time. Qualitative and quantitative participant feedback was collected via a brief, voluntary survey. All of the participants who completed the survey (n = 24) reported they were "very satisfied" (58.3%) or "somewhat satisfied" (41.7%) with the Summit., Next Steps: Physician involvement in social media presents opportunities for public health knowledge, medical education, scientific collaboration, and career advancement. Physicians who have been successful in using social media for these purposes are excellent peer educators and can fill the medical education void in social media training. Future plans include building sustainability of the program, collecting additional quantitative and qualitative feedback to guide improvement, and encouraging reproducibility., (Copyright © 2022 by the Association of American Medical Colleges.)
- Published
- 2022
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.